Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	DNA-binding transcription factor activity, RNA polymerase II-specific	FOXM1 TCF3 ZNF219 NEUROD4 GATA1 WT1 IRF5 POU5F1B ASCL3 HOXA6 HOXA11 HOXA13 GRHL1 HOXB9 NEUROG1 WIZ HOXD3 NFATC1 EGR4 NFE2L1 NFIB NFIC GLI2 TP63 ZNF746 SPDEF NFAT5 TAL1 NPAS4 TBX6	1.52e-06	1412	165	30	GO:0000981
GeneOntologyMolecularFunction	RNA polymerase II cis-regulatory region sequence-specific DNA binding	TCF3 ZNF219 NEUROD4 GATA1 WT1 IRF5 POU5F1B HOXA6 HOXA11 HOXA13 GRHL1 HOXB9 NEUROG1 WIZ HOXD3 NFATC1 EGR4 NFE2L1 NFIB NFIC GLI2 TP63 ZNF746 NFAT5 TAL1 NPAS4 TBX6	3.72e-06	1244	165	27	GO:0000978
GeneOntologyMolecularFunction	DNA-binding transcription activator activity, RNA polymerase II-specific	TCF3 GATA1 WT1 IRF5 POU5F1B HOXA13 GRHL1 HOXD3 NFATC1 EGR4 NFE2L1 NFIB NFIC GLI2 TP63 NFAT5 NPAS4	4.15e-06	560	165	17	GO:0001228
GeneOntologyMolecularFunction	DNA-binding transcription activator activity	TCF3 GATA1 WT1 IRF5 POU5F1B HOXA13 GRHL1 HOXD3 NFATC1 EGR4 NFE2L1 NFIB NFIC GLI2 TP63 NFAT5 NPAS4	4.77e-06	566	165	17	GO:0001216
GeneOntologyMolecularFunction	cis-regulatory region sequence-specific DNA binding	TCF3 ZNF219 NEUROD4 GATA1 WT1 IRF5 POU5F1B HOXA6 HOXA11 HOXA13 GRHL1 HOXB9 NEUROG1 WIZ HOXD3 NFATC1 EGR4 NFE2L1 NFIB NFIC GLI2 TP63 ZNF746 NFAT5 TAL1 NPAS4 TBX6	5.53e-06	1271	165	27	GO:0000987
GeneOntologyMolecularFunction	RNA polymerase II transcription regulatory region sequence-specific DNA binding	FOXM1 TCF3 ZNF219 NEUROD4 GATA1 WT1 IRF5 POU5F1B ASCL3 HOXA6 HOXA11 HOXA13 GRHL1 HOXB9 NEUROG1 WIZ HOXD3 NFATC1 EGR4 NFE2L1 NFIB NFIC GLI2 TP63 ZNF746 NFAT5 TAL1 NPAS4 TBX6	8.56e-06	1459	165	29	GO:0000977
GeneOntologyMolecularFunction	transcription factor binding	FLNA TCF3 RPS6KA1 GATA1 POU5F1B PPP1R13L GRHL1 WIZ NFATC1 BAZ2A MAP3K10 TACC1 NFAT5 TAL1 RBFOX2 TBX6	5.22e-04	753	165	16	GO:0008134
GeneOntologyMolecularFunction	protein serine kinase activity	HIPK4 RPS6KA1 BCR MAP3K1 PKMYT1 SIK2 MAP3K10 CDK11B MARK2 WNK3	9.01e-04	363	165	10	GO:0106310
GeneOntologyBiologicalProcess	positive regulation of transcription by RNA polymerase II	FOXM1 TCF3 ZNF219 VGLL2 NEUROD4 RPS6KA1 GATA1 WT1 IRF5 POU5F1B ASCL3 MAP3K1 HOXA13 GRHL1 HOXB9 NEUROG1 HOXD3 NFATC1 ATXN1 EGR4 NFE2L1 NFIB NFIC GLI2 TP63 ZNF746 SPDEF MCF2L NFAT5 TAL1 MAML3 NPAS4 TBX6	1.04e-08	1390	163	33	GO:0045944
GeneOntologyBiologicalProcess	cell fate commitment	IL12RB1 TCF3 NEUROD4 GATA1 WT1 POU5F1B HOXA11 HOXA13 NEUROG1 NFE2L1 NFIB GLI2 SPDEF TAL1 TBX6	8.14e-08	338	163	15	GO:0045165
GeneOntologyBiologicalProcess	cell morphogenesis	KIF13B HSPG2 FLNA SHROOM3 MYCBP2 WEE1 SIPA1L3 GATA1 SPART MAP3K1 MAPK8IP3 HOXA13 COL18A1 SIDT2 NFIB GLI2 NBEAL2 SEC24B KNDC1 MARK2 TAL1 CDH3 CDH7 MYO16 CDH15 RBFOX2 CNTN1	7.28e-07	1194	163	27	GO:0000902
GeneOntologyBiologicalProcess	epithelial cell differentiation	FLNA SHROOM3 CDHR2 SIPA1L3 GATA1 WT1 TSG101 BCR MAP3K1 HOXA13 COL18A1 GRHL1 SIDT2 NFE2L1 NFIB GLI2 TP63 SEC24B SPDEF MARVELD2 DMBT1 CDH3	1.45e-06	870	163	22	GO:0030855
GeneOntologyBiologicalProcess	epithelial cell development	FLNA SHROOM3 SIPA1L3 GATA1 WT1 MAP3K1 HOXA13 COL18A1 SIDT2 TP63 SPDEF MARVELD2	1.61e-06	269	163	12	GO:0002064
GeneOntologyBiologicalProcess	embryo development	HSPG2 TCF3 SHROOM3 DSC3 CLASP1 GATA1 WT1 APBA3 POU5F1B PPP1R13L BCR AHDC1 MAPK8IP3 HOXA6 HOXA11 HOXA13 COL18A1 HOXB9 NEUROG1 HOXD3 GLI2 TP63 SEC24B ANKRD11 CDK11B DMBT1 TAL1 TBX6	7.88e-06	1437	163	28	GO:0009790
GeneOntologyBiologicalProcess	epithelium development	FLNA SHROOM3 CLASP1 CDHR2 KIF26B SIPA1L3 GATA1 WT1 TSG101 ASCL3 BCR MAP3K1 HOXA11 HOXA13 COL18A1 GRHL1 SIDT2 NFATC1 NFE2L1 NFIB GLI2 TP63 SEC24B SPDEF MARVELD2 DMBT1 CDH3 TBX6	1.19e-05	1469	163	28	GO:0060429
GeneOntologyBiologicalProcess	negative regulation of DNA-templated transcription	FOXM1 FLNA TCF3 ZNF219 NOP53 GATA1 WT1 TSG101 POU5F1B PPP1R13L ASCL3 BEND6 NFATC1 ATXN1 BAZ2A NFE2L1 NFIB NFIC GLI2 TP63 ZNF746 MAP3K10 SPDEF TAL1 RBFOX2 TBX6	3.91e-05	1399	163	26	GO:0045892
GeneOntologyBiologicalProcess	negative regulation of RNA biosynthetic process	FOXM1 FLNA TCF3 ZNF219 NOP53 GATA1 WT1 TSG101 POU5F1B PPP1R13L ASCL3 BEND6 NFATC1 ATXN1 BAZ2A NFE2L1 NFIB NFIC GLI2 TP63 ZNF746 MAP3K10 SPDEF TAL1 RBFOX2 TBX6	4.61e-05	1413	163	26	GO:1902679
GeneOntologyBiologicalProcess	embryonic morphogenesis	HSPG2 TCF3 SHROOM3 CLASP1 POU5F1B BCR AHDC1 HOXA11 HOXA13 HOXB9 NEUROG1 HOXD3 GLI2 TP63 SEC24B TAL1 TBX6	5.17e-05	713	163	17	GO:0048598
GeneOntologyBiologicalProcess	definitive hemopoiesis	GATA1 BCR TAL1 RBFOX2	5.72e-05	27	163	4	GO:0060216
GeneOntologyBiologicalProcess	animal organ morphogenesis	HSPG2 FLNA KIF26B RPS6KA1 WT1 PPP1R13L BCR AHDC1 MAPK8IP3 HOXA11 HOXA13 COL18A1 HOXB9 NEUROG1 HOXD3 NFATC1 NFIB NFIC GLI2 ACAN TP63 SEC24B ANKRD11 TBX6	6.12e-05	1269	163	24	GO:0009887
GeneOntologyBiologicalProcess	genitalia development	WT1 HOXA13 NEUROG1 TP63 MERTK	6.70e-05	54	163	5	GO:0048806
GeneOntologyBiologicalProcess	negative regulation of transcription by RNA polymerase I	FLNA NOP53 BAZ2A	7.63e-05	11	163	3	GO:0016479
GeneOntologyBiologicalProcess	negative regulation of transcription by RNA polymerase II	FOXM1 TCF3 ZNF219 NOP53 GATA1 WT1 TSG101 POU5F1B PPP1R13L ASCL3 NFATC1 ATXN1 NFE2L1 NFIB NFIC GLI2 TP63 ZNF746 SPDEF TAL1 TBX6	8.82e-05	1053	163	21	GO:0000122
GeneOntologyBiologicalProcess	chondrocyte differentiation	HSPG2 ZNF219 SNX19 HOXA11 NFIB GLI2 ACAN	9.14e-05	133	163	7	GO:0002062
GeneOntologyBiologicalProcess	skeletal system development	HSPG2 ZNF219 SNX19 HOXA6 HOXA11 HOXA13 COL18A1 HOXB9 NEUROG1 HOXD3 NFIB GLI2 ACAN TP63 ANKRD11	1.13e-04	615	163	15	GO:0001501
GeneOntologyBiologicalProcess	mitotic cell cycle process	FOXM1 FLNA TCF3 CLASP1 WEE1 NOP53 MCM4 PKMYT1 HOXA13 AAAS NEUROG1 NFATC1 NFE2L1 NFIB SASS6 TACC1 CDK11B MYO16	1.48e-04	854	163	18	GO:1903047
GeneOntologyBiologicalProcess	mesodermal cell differentiation	POU5F1B HOXA11 TAL1 TBX6	1.63e-04	35	163	4	GO:0048333
GeneOntologyBiologicalProcess	cell cycle process	FOXM1 FLNA TCF3 CLASP1 WEE1 NOP53 AHCTF1 SPART MCM4 PKMYT1 HOXA13 AAAS NEUROG1 WIZ NFATC1 NFE2L1 NFIB STARD9 TP63 SASS6 TACC1 SPATA22 CDK11B PUM1 MYO16	1.66e-04	1441	163	25	GO:0022402
GeneOntologyBiologicalProcess	proximal/distal pattern formation	HOXA11 HOXB9 GLI2 TP63	2.03e-04	37	163	4	GO:0009954
GeneOntologyBiologicalProcess	hindbrain development	FLNA NFIB GLI2 SEC24B KNDC1 MYO16 RBFOX2 CNTN1	2.55e-04	208	163	8	GO:0030902
GeneOntologyBiologicalProcess	tissue morphogenesis	FLNA SHROOM3 CLASP1 KIF26B WT1 POU5F1B AHDC1 MAP3K1 HOXA11 HOXA13 NFATC1 GLI2 TP63 SEC24B TAL1 TBX6	3.07e-04	750	163	16	GO:0048729
GeneOntologyBiologicalProcess	columnar/cuboidal epithelial cell differentiation	SHROOM3 SIDT2 NFE2L1 NFIB TP63 SPDEF DMBT1	3.33e-04	164	163	7	GO:0002065
GeneOntologyBiologicalProcess	regulation of definitive erythrocyte differentiation	GATA1 RBFOX2	3.69e-04	4	163	2	GO:0010724
GeneOntologyBiologicalProcess	connective tissue development	HSPG2 ZNF219 WT1 SPART SNX19 HOXA11 HOXD3 NFIB GLI2 ACAN	4.13e-04	343	163	10	GO:0061448
GeneOntologyBiologicalProcess	mitotic cell cycle	FOXM1 FLNA TCF3 CLASP1 WEE1 NOP53 MCM4 PKMYT1 HOXA13 AAAS NEUROG1 NFATC1 NFE2L1 NFIB SASS6 TACC1 CDK11B TAL1 MYO16	4.26e-04	1014	163	19	GO:0000278
GeneOntologyBiologicalProcess	glial cell fate commitment	NFE2L1 NFIB TAL1	4.28e-04	19	163	3	GO:0021781
GeneOntologyBiologicalProcess	cell fate specification	POU5F1B HOXA11 HOXA13 NFIB GLI2 TBX6	4.41e-04	123	163	6	GO:0001708
GeneOntologyBiologicalProcess	positive regulation of neuron differentiation	TCF3 MAPK8IP3 NEUROG1 BEND6 HOXD3 GLI2	4.41e-04	123	163	6	GO:0045666
GeneOntologyBiologicalProcess	mesoderm formation	POU5F1B AHDC1 HOXA11 TAL1 TBX6	4.84e-04	82	163	5	GO:0001707
GeneOntologyBiologicalProcess	central nervous system development	HSPG2 FLNA MYCBP2 NEUROD4 BCR RTN1 MAPK8IP3 NEUROG1 ATXN1 NFE2L1 NFIB GLI2 ACAN SEC24B KNDC1 TACC1 IRS2 TAL1 MYO16 RBFOX2 CNTN1	5.01e-04	1197	163	21	GO:0007417
GeneOntologyBiologicalProcess	embryonic organ development	HSPG2 GATA1 PPP1R13L BCR HOXA11 COL18A1 HOXB9 NEUROG1 HOXD3 GLI2 SEC24B TAL1 TBX6	5.32e-04	561	163	13	GO:0048568
GeneOntologyCellularComponent	chromatin	FOXM1 TCF3 NOP53 NEUROD4 AHCTF1 GATA1 KDM3B IRF5 POU5F1B ASCL3 HOXA6 HOXA13 GRHL1 HOXB9 NEUROG1 HOXD3 NFATC1 BAZ2A EGR4 NFE2L1 NFIB NFIC TP63 BRD9 ANKRD11 SPDEF NFAT5 TAL1 NPAS4 TBX6	2.03e-06	1480	167	30	GO:0000785
MousePheno	abnormal eyelid development	PPP1R13L MAP3K1 WIZ NFIB SEC24B	1.25e-05	31	139	5	MP:0009651
Domain	Cadherin_C	DSC3 CDH3 CDH7 CDH15	5.84e-05	25	161	4	PF01049
Domain	Cadherin_cytoplasmic-dom	DSC3 CDH3 CDH7 CDH15	5.84e-05	25	161	4	IPR000233
Domain	BHLH	MYCLP1 TCF3 NEUROD4 ASCL3 NEUROG1 TAL1 NPAS4	6.96e-05	117	161	7	PS50888
Domain	bHLH_dom	MYCLP1 TCF3 NEUROD4 ASCL3 NEUROG1 TAL1 NPAS4	7.34e-05	118	161	7	IPR011598
Domain	Glyco_hydro_99	MANEA MANEAL	7.39e-05	2	161	2	PF16317
Domain	Glyco_Hydrolase_99	MANEA MANEAL	7.39e-05	2	161	2	IPR026071
Domain	Yif1_fam	YIF1A YIF1B	7.39e-05	2	161	2	IPR005578
Domain	AT_hook	AHCTF1 AHDC1 PRR12 BAZ2A	8.00e-05	27	161	4	SM00384
Domain	AT_hook_DNA-bd_motif	AHCTF1 AHDC1 PRR12 BAZ2A	8.00e-05	27	161	4	IPR017956
Domain	Catenin_binding_dom	DSC3 CDH3 CDH7 CDH15	1.07e-04	29	161	4	IPR027397
Domain	-	DSC3 CDH3 CDH7 CDH15	1.07e-04	29	161	4	4.10.900.10
Domain	AT_hook	AHCTF1 PRR12 BAZ2A	3.24e-04	16	161	3	PF02178
Domain	Cadherin_CS	DSC3 CDHR2 PCDHGA4 CDH3 CDH7 CDH15	3.64e-04	109	161	6	IPR020894
Domain	-	TCF3 NEUROD4 ASCL3 NEUROG1 TAL1 NPAS4	3.64e-04	109	161	6	4.10.280.10
Domain	HLH	MYCLP1 TCF3 NEUROD4 ASCL3 NEUROG1 TAL1	4.02e-04	111	161	6	PF00010
Domain	CTF_NFI	NFIB NFIC	4.38e-04	4	161	2	PF00859
Domain	CTF_NFI_1	NFIB NFIC	4.38e-04	4	161	2	PS00349
Domain	CTF_NFI_2	NFIB NFIC	4.38e-04	4	161	2	PS51080
Domain	CTF/NFI_DNA-bd-dom	NFIB NFIC	4.38e-04	4	161	2	IPR020604
Domain	NfI_DNAbd_pre-N	NFIB NFIC	4.38e-04	4	161	2	PF10524
Domain	CTF/NFI	NFIB NFIC	4.38e-04	4	161	2	IPR000647
Domain	CTF/NFI_DNA-bd_N	NFIB NFIC	4.38e-04	4	161	2	IPR019548
Domain	CTF/NFI_DNA-bd_CS	NFIB NFIC	4.38e-04	4	161	2	IPR019739
Domain	CADHERIN_1	DSC3 CDHR2 PCDHGA4 CDH3 CDH7 CDH15	4.42e-04	113	161	6	PS00232
Domain	Cadherin	DSC3 CDHR2 PCDHGA4 CDH3 CDH7 CDH15	4.42e-04	113	161	6	PF00028
Domain	CADHERIN_2	DSC3 CDHR2 PCDHGA4 CDH3 CDH7 CDH15	4.63e-04	114	161	6	PS50268
Domain	-	DSC3 CDHR2 PCDHGA4 CDH3 CDH7 CDH15	4.63e-04	114	161	6	2.60.40.60
Domain	Pkinase	HIPK4 WEE1 RPS6KA1 MAP3K1 PKMYT1 TBCK SIK2 MAP3K10 CDK11B MARK2 WNK3	4.79e-04	381	161	11	PF00069
Domain	CA	DSC3 CDHR2 PCDHGA4 CDH3 CDH7 CDH15	4.85e-04	115	161	6	SM00112
Domain	HLH	MYCLP1 TCF3 NEUROD4 ASCL3 NEUROG1 TAL1	5.08e-04	116	161	6	SM00353
Domain	Cadherin-like	DSC3 CDHR2 PCDHGA4 CDH3 CDH7 CDH15	5.08e-04	116	161	6	IPR015919
Domain	Cadherin	DSC3 CDHR2 PCDHGA4 CDH3 CDH7 CDH15	5.56e-04	118	161	6	IPR002126
Domain	NFAT	NFATC1 NFAT5	7.26e-04	5	161	2	IPR008366
Domain	Kinase-like_dom	HIPK4 WEE1 RPS6KA1 MAP3K1 PKMYT1 TBCK KNDC1 SIK2 MAP3K10 CDK11B MARK2 MERTK WNK3	8.56e-04	542	161	13	IPR011009
Domain	Sec23/24_helical_dom	SEC24B SEC23A	1.08e-03	6	161	2	IPR006900
Domain	Sec23_24_beta_S	SEC24B SEC23A	1.08e-03	6	161	2	IPR012990
Domain	zf-Sec23_Sec24	SEC24B SEC23A	1.08e-03	6	161	2	PF04810
Domain	Sec23_trunk	SEC24B SEC23A	1.08e-03	6	161	2	PF04811
Domain	Sec23_helical	SEC24B SEC23A	1.08e-03	6	161	2	PF04815
Domain	Sec23_BS	SEC24B SEC23A	1.08e-03	6	161	2	PF08033
Domain	Sec23/24_trunk_dom	SEC24B SEC23A	1.08e-03	6	161	2	IPR006896
Domain	Znf_Sec23_Sec24	SEC24B SEC23A	1.08e-03	6	161	2	IPR006895
Domain	Ser/Thr_kinase_AS	HIPK4 WEE1 RPS6KA1 MAP3K1 PKMYT1 SIK2 MAP3K10 CDK11B MARK2 WNK3	1.09e-03	357	161	10	IPR008271
Domain	Prot_kinase_dom	HIPK4 WEE1 RPS6KA1 MAP3K1 PKMYT1 TBCK SIK2 MAP3K10 CDK11B MARK2 MERTK WNK3	1.11e-03	489	161	12	IPR000719
Domain	p53-like_TF_DNA-bd	NFATC1 TP63 NFAT5 TBX6	1.12e-03	53	161	4	IPR008967
Domain	S_TKc	HIPK4 WEE1 RPS6KA1 MAP3K1 PKMYT1 SIK2 MAP3K10 CDK11B MARK2 WNK3	1.13e-03	359	161	10	SM00220
Domain	PROTEIN_KINASE_DOM	HIPK4 WEE1 RPS6KA1 MAP3K1 PKMYT1 TBCK SIK2 MAP3K10 CDK11B MARK2 MERTK WNK3	1.19e-03	493	161	12	PS50011
Domain	PROTEIN_KINASE_ST	HIPK4 WEE1 RPS6KA1 MAP3K1 PKMYT1 SIK2 MAP3K10 CDK11B MARK2 WNK3	1.21e-03	362	161	10	PS00108
Domain	Cadherin_pro	DSC3 CDH3	2.00e-03	8	161	2	SM01055
Domain	Cadherin_pro_dom	DSC3 CDH3	2.00e-03	8	161	2	IPR014868
Domain	PROTEIN_KINASE_ATP	HIPK4 WEE1 RPS6KA1 MAP3K1 PKMYT1 SIK2 MAP3K10 CDK11B MARK2 MERTK WNK3	2.15e-03	459	161	11	PS00107
Domain	HMGI/Y_DNA-bd_CS	AHCTF1 PRR12 BAZ2A	2.37e-03	31	161	3	IPR000637
Pathway	REACTOME_POLO_LIKE_KINASE_MEDIATED_EVENTS	FOXM1 WEE1 PKMYT1	4.70e-06	5	111	3	MM14602
Pathway	SA_B_CELL_RECEPTOR_COMPLEXES	RPS6KA1 BCR MAP3K1 MAPK8IP3	3.43e-05	24	111	4	M17200
Pubmed	A genome-wide screen to identify transcription factors expressed in pelvic Ganglia of the lower urinary tract.	FOXM1 TCF3 ZNF219 SH3RF1 NEUROD4 GATA1 WT1 IRF5 ZDHHC3 HOXA6 HOXA11 HOXA13 GRHL1 HOXB9 HOXD3 BAZ2A NFE2L1 GLI2 ZNF746 BRD9 SPDEF NFAT5 MAML3 NPAS4	9.68e-14	709	169	24	22988430
Pubmed	A census of human transcription factors: function, expression and evolution.	FOXM1 TCF3 NEUROD4 AHCTF1 GATA1 WT1 IRF5 POU5F1B ASCL3 HOXA6 HOXA11 HOXA13 GRHL1 HOXB9 NEUROG1 HOXD3 NFATC1 NFE2L1 NFIB NFIC GLI2 TP63 SPDEF NFAT5 TAL1 TBX6	3.86e-13	908	169	26	19274049
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	KIF13B ATXN2L SHROOM3 SH3RF1 HIPK4 CLASP1 MYCBP2 WEE1 KIF26B SIPA1L3 KDM3B BCR ATXN1 STARD9 SEC24B ANKRD11 SIK2 MAP3K10 IRS2 MARK2 PUM1 USP6NL WNK3	3.95e-11	861	169	23	36931259
Pubmed	An atlas of combinatorial transcriptional regulation in mouse and man.	FOXM1 ELOA TCF3 ZNF219 NEUROD4 GATA1 WT1 MCM4 IRF5 TSG101 ASCL3 HOXA6 HOXA11 HOXB9 NEUROG1 HOXD3 NFE2L1 NFIC TP63 SPDEF TAL1 MAML3 RBFOX2	5.68e-11	877	169	23	20211142
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	HSPG2 FLNA SHROOM3 SETD1B SH3RF1 MYCBP2 TMEM158 SIPA1L3 MYOM3 KDM3B IRF5 BCR AHDC1 MAPK8IP3 PKMYT1 PRR12 URB1 WIZ NFATC1 NBEAL2 ANKRD11 IRS2 MCF2L PUM1	9.34e-10	1105	169	24	35748872
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	FOXM1 ATXN2L FLNA ELOA HIRIP3 CLASP1 MYCBP2 WEE1 WRNIP1 KDM3B MCM4 GPATCH8 MAPK8IP3 NOL4L BAZ2A NFIC IRS2 CDK11B COASY MARK2	1.44e-09	774	169	20	15302935
Pubmed	Impact of cytosine methylation on DNA binding specificities of human transcription factors.	GATA1 IRF5 HOXA6 HOXA11 HOXA13 GRHL1 HOXB9 NEUROG1 HOXD3 NFATC1 EGR4 NFIB NFIC GLI2 SPDEF NFAT5 TBX6	1.61e-09	544	169	17	28473536
Pubmed	A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.	TCF3 HIRIP3 CLASP1 WEE1 TICAM1 WRNIP1 KDM3B APBA3 TSG101 PPP1R13L BCR MAP3K1 AAAS SEC24B KNDC1 SIK2 IRS2 POLD3 HEATR5B PUM1 SEC23A	3.85e-08	1038	169	21	26673895
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	TCF3 SHROOM3 MYCBP2 CACNA2D2 SIPA1L3 ANKMY1 BCR NAALADL2 AHDC1 MAPK8IP3 COL18A1 NFATC1 ATXN1 NFIB NFIC GLI2 FBXO42 TBCK ANKRD11 KNDC1 MCF2L NFAT5 MAML3 CDH15 RBFOX2	6.66e-08	1489	169	25	28611215
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	ATXN2L ELOA CLASP1 MYCBP2 NDUFAF2 WRNIP1 KDM3B GPATCH8 PPP1R13L BCR ZDHHC3 RTN1 AAAS TACC1 CDK11B POLD3 PUM1	1.24e-07	733	169	17	34672954
Pubmed	An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase.	TCF3 SHROOM3 AHCTF1 SPART PRR12 NFIB NFIC MARK2 USP6NL	2.67e-07	180	169	9	35198878
Pubmed	Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.	FOXM1 ZNF219 AHCTF1 GATA1 WT1 KDM3B POU5F1B ZDHHC3 GRHL1 WIZ NFATC1 ATXN1 BAZ2A NFE2L1 NFIB SPDEF NFAT5	4.84e-07	808	169	17	20412781
Pubmed	The proximal proteome of 17 SARS-CoV-2 proteins links to disrupted antiviral signaling and host translation.	DSC3 MYCBP2 NDUFAF2 AHCTF1 SIPA1L3 SPART ZDHHC3 PKMYT1 COL18A1 YIF1A YIF1B WIZ SEC24B TACC1 MARK2 CWF19L1 USP6NL PIGO RBFOX2	5.16e-07	1007	169	19	34597346
Pubmed	Association of erythroid transcription factors: complexes involving the LIM protein RBTN2 and the zinc-finger protein GATA1.	TCF3 GATA1 TAL1	1.12e-06	5	169	3	7568177
Pubmed	LIM-only protein Lmo2 forms a protein complex with erythroid transcription factor GATA-1.	TCF3 GATA1 TAL1	1.12e-06	5	169	3	9209374
Pubmed	SCL and associated proteins distinguish active from repressive GATA transcription factor complexes.	TCF3 GATA1 TAL1	1.12e-06	5	169	3	19011221
Pubmed	Complete mutation analysis panel of the 39 human HOX genes.	HOXA6 HOXA11 HOXA13 HOXB9 HOXD3	1.13e-06	38	169	5	11857506
Pubmed	Lysine demethylase 7a regulates murine anterior-posterior development by modulating the transcription of Hox gene cluster.	HOXA6 HOXA11 HOXA13 HOXB9 HOXD3	1.29e-06	39	169	5	33257809
Pubmed	Quantification of Hox and surfactant protein-B transcription during murine lung development.	HOXA6 HOXA11 HOXA13 HOXB9 HOXD3	1.46e-06	40	169	5	19204410
Pubmed	Lin28a/let-7 pathway modulates the Hox code via Polycomb regulation during axial patterning in vertebrates.	HOXA6 HOXA11 HOXA13 HOXB9 HOXD3	1.66e-06	41	169	5	32479258
Pubmed	A dynamic expression survey identifies transcription factors relevant in mouse digestive tract development.	TCF3 HOXA6 HOXA11 HOXA13 HOXB9 HOXD3 SPDEF	1.89e-06	118	169	7	16971476
Pubmed	Reduction of Hox gene expression by histone H1 depletion.	HOXA6 HOXA11 HOXA13 HOXB9 HOXD3	2.12e-06	43	169	5	22701719
Pubmed	Nomenclature for human homeobox genes.	HOXA6 HOXA11 HOXA13 HOXB9 HOXD3	2.38e-06	44	169	5	1973146
Pubmed	Vertebrate homeobox gene nomenclature.	HOXA6 HOXA11 HOXA13 HOXB9 HOXD3	3.32e-06	47	169	5	1358459
Pubmed	Hoxa10 mediates positional memory to govern stem cell function in adult skeletal muscle.	HOXA6 HOXA11 HOXA13	3.89e-06	7	169	3	34108202
Pubmed	Eto2/MTG16 and MTGR1 are heteromeric corepressors of the TAL1/SCL transcription factor in murine erythroid progenitors.	TCF3 GATA1 TAL1	3.89e-06	7	169	3	19799863
Pubmed	New insights into the role of Jmjd3 and Utx in axial skeletal formation in mice.	HOXA6 HOXA11 HOXA13 HOXB9 HOXD3	4.53e-06	50	169	5	28188179
Pubmed	Identification of genes contributing to the obese yellow Avy phenotype: caloric restriction, genotype, diet x genotype interactions.	FLNA SHROOM3 CACNA2D2 TAL1 CDH3	6.07e-06	53	169	5	15306695
Pubmed	The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation.	FLNA WRNIP1 NDFIP1 HOXA11 HOXA13 HOXB9 WIZ NFATC1 ATXN1 BAZ2A NFIB NFIC NFAT5	6.13e-06	583	169	13	29844126
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	FOXM1 KIF13B ATXN2L SETD1B SH3RF1 CLASP1 WEE1 SPART BCR NFATC1 FBXO42 SASS6 CDK11B	6.71e-06	588	169	13	38580884
Pubmed	Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.	WRNIP1 KDM3B AHDC1 PRR12 GRHL1 WIZ ATXN1 NFIB NFIC	7.15e-06	268	169	9	33640491
Pubmed	Fine mapping of human HOX gene clusters.	HOXA6 HOXA11 HOXA13 HOXB9	7.40e-06	26	169	4	8646877
Pubmed	Hair follicle stem cells are specified and function in early skin morphogenesis.	TCF3 NFATC1 TP63 CDH3	7.40e-06	26	169	4	18593557
Pubmed	High-resolution gene expression analysis of the developing mouse kidney defines novel cellular compartments within the nephron progenitor population.	TCF3 ZNF219 WT1 HOXA6 HOXA11	7.98e-06	56	169	5	19591821
Pubmed	Phylogenetic and expression analysis of the basic helix-loop-helix transcription factor gene family: genomic approach to cellular differentiation.	TCF3 NEUROD4 ASCL3 NEUROG1 TAL1 NPAS4	8.76e-06	98	169	6	18557763
Pubmed	Targeted proteomic analysis of 14-3-3 sigma, a p53 effector commonly silenced in cancer.	SHROOM3 MYCBP2 WEE1 SIPA1L3 IRS2 MARK2	1.10e-05	102	169	6	15778465
Pubmed	A genome-wide screen for spatially restricted expression patterns identifies transcription factors that regulate glial development.	FOXM1 TCF3 NEUROD4 HOXD3 EGR4 NFIB	1.10e-05	102	169	6	19741146
Pubmed	The human HOX gene family.	HOXA11 HOXA13 HOXB9 HOXD3	1.16e-05	29	169	4	2574852
Pubmed	The Epigenetic Factor Landscape of Developing Neocortex Is Regulated by Transcription Factors Pax6→ Tbr2→ Tbr1.	SETD1B KDM3B BAZ2A BRD9 ANKRD11 CDH3 CDH7	1.25e-05	157	169	7	30186101
Pubmed	Prediction of the coding sequences of unidentified human genes. IX. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.	CACNA2D2 SIPA1L3 SPART GPATCH8 URB1 NBEAL2	1.30e-05	105	169	6	9628581
Pubmed	Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette.	TCF3 SHROOM3 CLASP1 NDUFAF2 SIPA1L3 AHDC1 SIDT2 GLI2 ANKRD11 TACC1 MARK2 PUM1	1.35e-05	536	169	12	15840001
Pubmed	Exchangeable gene trap using the Cre/mutated lox system.	TCF3 SHROOM3 CLASP1 NDUFAF2 SIPA1L3 AHDC1 SIDT2 GLI2 ANKRD11 TACC1 MARK2 PUM1	1.40e-05	538	169	12	10512203
Pubmed	DNA-binding specificities of human transcription factors.	IRF5 HOXA13 EGR4 SPDEF	1.53e-05	31	169	4	23332764
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	ATXN2L FLNA ELOA NOP53 AHCTF1 MCM4 HOXA13 HOXB9 DHRS4 WIZ BAZ2A BRD9 ANKRD11 SPATA22 CDK11B PUM1	1.85e-05	954	169	16	36373674
Pubmed	E-cadherin interactome complexity and robustness resolved by quantitative proteomics.	ATXN2L FLNA SHROOM3 SH3RF1 DSC3 SIPA1L3 PPP1R13L SEC24B VSIG10L MARVELD2 MARK2 USP6NL	2.27e-05	565	169	12	25468996
Pubmed	Involvement of CDK11B-mediated SPDEF ubiquitination and SPDEF-mediated microRNA-448 activation in the oncogenicity and self-renewal of hepatocellular carcinoma stem cells.	SPDEF CDK11B	2.35e-05	2	169	2	33328586
Pubmed	ΔNp63α enhances the oncogenic phenotype of osteosarcoma cells by inducing the expression of GLI2.	GLI2 TP63	2.35e-05	2	169	2	25085524
Pubmed	P-cadherin is a p63 target gene with a crucial role in the developing human limb bud and hair follicle.	TP63 CDH3	2.35e-05	2	169	2	18199584
Pubmed	Alternative transcription initiation and splicing variants of the DHRS4 gene cluster.	DHRS4L2 DHRS4	2.35e-05	2	169	2	18754758
Pubmed	Wilms' tumor gene 1 regulates p63 and promotes cell proliferation in squamous cell carcinoma of the head and neck.	WT1 TP63	2.35e-05	2	169	2	25929687
Pubmed	The role of NFAT transcription factors in integrin-mediated carcinoma invasion.	NFATC1 NFAT5	2.35e-05	2	169	2	12080349
Pubmed	The Tal1 oncoprotein inhibits E47-mediated transcription. Mechanism of inhibition.	TCF3 TAL1	2.35e-05	2	169	2	9507011
Pubmed	The DNA binding activity of TAL-1 is not required to induce leukemia/lymphoma in mice.	TCF3 TAL1	2.35e-05	2	169	2	11439353
Pubmed	CDNA cloning of a short isoform of human liver NADP (H) -dependent retinol dehydrogenase/reductase and analysis of its characteristics.	DHRS4L2 DHRS4	2.35e-05	2	169	2	15473316
Pubmed	SPDEF is overexpressed in gastric cancer and triggers cell proliferation by forming a positive regulation loop with FoxM1.	FOXM1 SPDEF	2.35e-05	2	169	2	30076647
Pubmed	Expression of a novel alternatively spliced variant of NADP(H)-dependent retinol dehydrogenase/reductase with deletion of exon 3 in cervical squamous carcinoma.	DHRS4L2 DHRS4	2.35e-05	2	169	2	17230527
Pubmed	Deletion of the basement membrane heparan sulfate proteoglycan type XVIII collagen causes hypertriglyceridemia in mice and humans.	HSPG2 COL18A1	2.35e-05	2	169	2	21085708
Pubmed	Heparan sulfate chains of perlecan are indispensable in the lens capsule but not in the kidney.	HSPG2 COL18A1	2.35e-05	2	169	2	12514129
Pubmed	Expression of tal-1 and GATA-binding proteins during human hematopoiesis.	GATA1 TAL1	2.35e-05	2	169	2	7678994
Pubmed	Transcriptional diversity during lineage commitment of human blood progenitors.	NFIB NFIC	2.35e-05	2	169	2	25258084
Pubmed	iASPP/p63 autoregulatory feedback loop is required for the homeostasis of stratified epithelia.	PPP1R13L TP63	2.35e-05	2	169	2	21897369
Pubmed	The transcription factor GATA1 regulates NBEAL2 expression through a long-distance enhancer.	GATA1 NBEAL2	2.35e-05	2	169	2	28082341
Pubmed	Decoding hematopoietic specificity in the helix-loop-helix domain of the transcription factor SCL/Tal-1.	TCF3 TAL1	2.35e-05	2	169	2	15314159
Pubmed	Nuclear accumulation of glioma-associated oncogene 2 protein and enhanced expression of forkhead-box transcription factor M1 protein in human hepatocellular carcinoma.	FOXM1 GLI2	2.35e-05	2	169	2	20712011
Pubmed	Epigenetic Regulation of iASPP-p63 Feedback Loop in Cutaneous Squamous Cell Carcinoma.	PPP1R13L TP63	2.35e-05	2	169	2	30710576
Pubmed	Pumilio1 haploinsufficiency leads to SCA1-like neurodegeneration by increasing wild-type Ataxin1 levels.	ATXN1 PUM1	2.35e-05	2	169	2	25768905
Pubmed	WT1 regulates HOXB9 gene expression in a bidirectional way.	WT1 HOXB9	2.35e-05	2	169	2	34508900
Pubmed	Genome-Wide Organization of GATA1 and TAL1 Determined at High Resolution.	GATA1 TAL1	2.35e-05	2	169	2	26503782
Pubmed	A GATA box in the GATA-1 gene hematopoietic enhancer is a critical element in the network of GATA factors and sites that regulate this gene.	GATA1 TAL1	2.35e-05	2	169	2	10611250
Pubmed	Fuz controls the morphogenesis and differentiation of hair follicles through the formation of primary cilia.	GLI2 TP63 CDH3	2.40e-05	12	169	3	20962855
Pubmed	Excessive versus physiologically relevant levels of retinoic acid in embryonic stem cell differentiation.	HOXA6 HOXA11 HOXA13	2.40e-05	12	169	3	25099890
Pubmed	Orientation of the Hoxa complex and placement of the Hd locus distal to Hoxa2 on mouse chromosome 6.	HOXA6 HOXA11 HOXA13	2.40e-05	12	169	3	8833244
Pubmed	Genomic maps and comparative analysis of histone modifications in human and mouse.	HOXA6 HOXA11 HOXA13	2.40e-05	12	169	3	15680324
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	ATXN2L FLNA TCF3 CLASP1 MYCBP2 GATA1 WRNIP1 WT1 KDM3B MCM4 AHDC1 PRR12 HOXA13 NOL4L WIZ NFIC BRD9	2.93e-05	1103	169	17	34189442
Pubmed	Localization of human cadherin genes to chromosome regions exhibiting cancer-related loss of heterozygosity.	CDH3 CDH7 CDH15	3.11e-05	13	169	3	9615235
Pubmed	Atlas of Hox gene expression in the developing kidney.	HOXA6 HOXA11 HOXB9 HOXD3	3.49e-05	38	169	4	15042701
Pubmed	Identification of 10 murine homeobox genes.	HOXA6 HOXA11 HOXB9 HOXD3	3.49e-05	38	169	4	1683707
Pubmed	The mouse Ulnaless mutation deregulates posterior HoxD gene expression and alters appendicular patterning.	HOXA11 HOXA13 HOXD3	3.94e-05	14	169	3	9342041
Pubmed	Systematic protein-protein interaction mapping for clinically relevant human GPCRs.	TMEM42 EFS SPART ZDHHC3 RTN1 NACAD MAP3K1 NDFIP1 YIF1A YIF1B BAZ2A PLCH2 CNTN1	3.97e-05	697	169	13	28298427
Pubmed	The AERO system: a 3D-like approach for recording gene expression patterns in the whole mouse embryo.	ZNF219 GATA1 HOXA11 HOXD3 GLI2 TP63 SPDEF	4.39e-05	191	169	7	24146773
Pubmed	TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions.	ATXN2L FLNA ELOA WEE1 SIPA1L3 TSG101 PPP1R13L COL18A1 URB1 ZNF746 SEC24B ANKRD11 MERTK PUM1 SEC23A	4.80e-05	922	169	15	27609421
Pubmed	p63 control of desmosome gene expression and adhesion is compromised in AEC syndrome.	DSC3 TP63 CDH3	4.91e-05	15	169	3	23108156
Pubmed	Modulation of Dhh signaling and altered Sertoli cell function in mice lacking the GPR37-prosaposin receptor.	GATA1 WT1 GLI2	4.91e-05	15	169	3	25609427
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	SHROOM3 WEE1 WT1 TSG101 MAP3K1 NFE2L1 GLI2 TP63 PLCH2 UBQLN3	5.24e-05	430	169	10	35044719
Pubmed	Identification of the SOX2 Interactome by BioID Reveals EP300 as a Mediator of SOX2-dependent Squamous Differentiation and Lung Squamous Cell Carcinoma Growth.	PRR12 WIZ NFIB NFIC TP63	5.46e-05	83	169	5	28794006
Pubmed	Interaction network of human early embryonic transcription factors.	AHDC1 PRR12 HOXB9 WIZ ATXN1 NFIB NFIC ZNF746 BRD9	5.95e-05	351	169	9	38297188
Pubmed	Recruitment of 5' Hoxa genes in the allantois is essential for proper extra-embryonic function in placental mammals.	HOXA6 HOXA11 HOXA13	6.03e-05	16	169	3	22219351
Pubmed	Endothelial cell interactions initiate dorsal pancreas development by selectively inducing the transcription factor Ptf1a.	WT1 NEUROG1 TAL1	6.03e-05	16	169	3	14736742
Pubmed	Kif7 regulates Gli2 through Sufu-dependent and -independent functions during skin development and tumorigenesis.	GLI2 TP63 CDH3	6.03e-05	16	169	3	23034632
Pubmed	Transcriptome of the inner circular smooth muscle of the developing mouse intestine: Evidence for regulation of visceral smooth muscle genes by the hedgehog target gene, cJun.	FLNA TCF3 CTTNBP2 EFS HOXD3 TAL1	6.60e-05	140	169	6	26930384
Pubmed	FOX-2 dependent splicing of ataxin-2 transcript is affected by ataxin-1 overexpression.	ATXN1 RBFOX2	7.02e-05	3	169	2	22666429
Pubmed	CpG island evolution in the mammalian DHRS4 gene cluster and its role in the regulation of gene transcription.	DHRS4L2 DHRS4	7.02e-05	3	169	2	27323117
Pubmed	Topographical variation in the distributions of versican, aggrecan and perlecan in the foetal human spine reflects their diverse functional roles in spinal development.	HSPG2 ACAN	7.02e-05	3	169	2	19669783
Pubmed	Expression of Scl in mesoderm rescues hematopoiesis in the absence of Oct-4.	POU5F1B TAL1	7.02e-05	3	169	2	19321862
Pubmed	Identification of peroxisomal proteins by using M13 phage protein VI phage display: molecular evidence that mammalian peroxisomes contain a 2,4-dienoyl-CoA reductase.	DHRS4L2 DHRS4	7.02e-05	3	169	2	10333503
Pubmed	Mixed lineage kinase phosphorylates transcription factor E47 and inhibits TrkB expression to link neuronal death and survival pathways.	TCF3 MAP3K10	7.02e-05	3	169	2	19801649
Pubmed	Differential use of SCL/TAL-1 DNA-binding domain in developmental hematopoiesis.	TCF3 TAL1	7.02e-05	3	169	2	18550854
Pubmed	Bioinformatic analysis of the human DHRS4 gene cluster and a proposed mechanism for its transcriptional regulation.	DHRS4L2 DHRS4	7.02e-05	3	169	2	20525226
Pubmed	SPDEF inhibits prostate carcinogenesis by disrupting a positive feedback loop in regulation of the Foxm1 oncogene.	FOXM1 SPDEF	7.02e-05	3	169	2	25254494
Pubmed	The miR-124-p63 feedback loop modulates colorectal cancer growth.	PPP1R13L TP63	7.02e-05	3	169	2	28418858
Interaction	SFN interactions	KIF13B ATXN2L TCF3 SHROOM3 SH3RF1 CLASP1 MYCBP2 WEE1 KIF26B SIPA1L3 BCR ATXN1 NFIB NFIC TP63 SIK2 MAP3K10 IRS2 MARK2 PUM1 USP6NL	2.20e-07	692	164	21	int:SFN
Interaction	YWHAQ interactions	KIF13B ATXN2L FLNA TCF3 SHROOM3 SH3RF1 CLASP1 MYCBP2 WEE1 KIF26B RPS6KA1 SIPA1L3 BCR MAP3K1 NFATC1 ATXN1 STARD9 SIK2 MAP3K10 IRS2 CDK11B MARK2 MERTK PUM1 USP6NL	4.07e-06	1118	164	25	int:YWHAQ
Interaction	CREBBP interactions	FOXM1 TCF3 RPS6KA1 GATA1 WT1 KDM3B IRF5 PPP1R13L HOXA11 HOXB9 NEUROG1 NFATC1 ATXN1 NFIB NFIC MARK2 TAL1	8.21e-06	599	164	17	int:CREBBP
Interaction	YWHAB interactions	KIF13B ATXN2L SHROOM3 SH3RF1 CLASP1 MYCBP2 WEE1 KIF26B RPS6KA1 SIPA1L3 BCR ATXN1 STARD9 SIK2 MAP3K10 IRS2 CDK11B MARK2 MERTK PUM1 CWF19L1 USP6NL	2.60e-05	1014	164	22	int:YWHAB
Interaction	YWHAG interactions	KIF13B ATXN2L FLNA SHROOM3 SH3RF1 CLASP1 MYCBP2 WEE1 KIF26B RPS6KA1 SIPA1L3 KDM3B BCR MAP3K1 ATXN1 STARD9 SEC24B ANKRD11 SIK2 MAP3K10 IRS2 CDK11B MARK2 PUM1 USP6NL	2.66e-05	1248	164	25	int:YWHAG
Interaction	YWHAH interactions	KIF13B ATXN2L SHROOM3 SH3RF1 CLASP1 MYCBP2 WEE1 KIF26B RPS6KA1 SIPA1L3 KDM3B BCR ATXN1 STARD9 SEC24B ANKRD11 SIK2 MAP3K10 IRS2 MARK2 PUM1 USP6NL WNK3	3.08e-05	1102	164	23	int:YWHAH
GeneFamily	HOXL subclass homeoboxes	HOXA6 HOXA11 HOXA13 HOXB9 HOXD3	1.65e-05	52	111	5	518
GeneFamily	Mannosidases endo-alpha	MANEA MANEAL	3.74e-05	2	111	2	1195
GeneFamily	Basic helix-loop-helix proteins	TCF3 NEUROD4 ASCL3 NEUROG1 TAL1 NPAS4	5.96e-05	110	111	6	420
GeneFamily	Nuclear factors of activated T-cells	NFATC1 NFAT5	3.69e-04	5	111	2	665
GeneFamily	CD molecules\|Type I classical cadherins	CDH3 CDH15	3.69e-04	5	111	2	1185
GeneFamily	YIP family	YIF1A YIF1B	3.69e-04	5	111	2	1144
GeneFamily	Hyalectan proteoglycans\|V-set domain containing\|Sushi domain containing\|C-type lectin domain containing	MASP1 SUSD4 CSMD2 ACAN	4.14e-04	57	111	4	1179
GeneFamily	Kinesins\|Pleckstrin homology domain containing	KIF13B KIF26B STARD9	2.82e-03	46	111	3	622
GeneFamily	StAR related lipid transfer domain containing	STARD8 STARD9	3.72e-03	15	111	2	759
ToppCell	COVID-19-lung-Secretory\|lung / Disease (COVID-19 only), tissue and cell type	SHROOM3 SUSD4 DSC3 FER1L6 GRHL1 TP63 TMC5 CDH3	6.85e-07	189	170	8	84d48e3ed25bebb8bb8074b3a2c5e2e88cff7f25
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	KIF13B SHROOM3 SIPA1L3 NAALADL2 NOL4L NFIB NBEAL2 TMC5	7.42e-07	191	170	8	3e828cffa24ded19f591a7ed6c1fe88ad57fdcac
ToppCell	Parenchymal-NucSeq\|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations	SHROOM3 SH3RF1 CLASP1 SIPA1L3 NAALADL2 ATXN1 MAML3 RBFOX2	9.72e-07	198	170	8	1996373bdccc55aac347d349bd22f6aad6d0c668
ToppCell	Tracheal-NucSeq-Epithelial-Epi_submucosal-gland\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SHROOM3 SH3RF1 NAALADL2 RTN1 SPDEF MCF2L TMC5 MAML3	1.05e-06	200	170	8	0eb9ad8c0373bcc62029ec21c590ed03aaacd039
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-1M-IPC_like\|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type.	HIPK4 NEUROD4 TMEM158 SLCO5A1 NEUROG1 NFIB MAML3	2.36e-06	156	170	7	7e6805ebc7bc2f9c5965321d16922c155719970f
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-1M-IPC_like-IPs_and_early_cortical_neurons\|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type.	HIPK4 NEUROD4 TMEM158 SLCO5A1 NEUROG1 NFIB MAML3	2.36e-06	156	170	7	741de05295b2d012ac8576378f37709a97c8fb50
ToppCell	facs-Aorta-Heart-24m-Endothelial-endocardial_endothelial_cells\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MASP1 TMEM42 PLPPR5 BCR HOXA6 HOXB9 KDSR	3.85e-06	168	170	7	edbab94f14e16a1a76546a18fe777a183080d1de
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	WT1 HOXA13 STARD9 TMC5 CDH7 MAML3 CNTN1	4.50e-06	172	170	7	08a3fe536b1b064c5ee7779bc2b1115a5963a26b
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	WT1 HOXA13 STARD9 TMC5 CDH7 MAML3 CNTN1	4.50e-06	172	170	7	553701349444eb366df3c11f54bb093434f153c6
ToppCell	E18.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	IL12RB1 GATA1 MCTP1 NBEAL2 IL21R TAL1 NPAS4	6.06e-06	180	170	7	ca2a35bfb67347e47f511589a3d0f763e6664634
ToppCell	E18.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet-Megakaryocyte/Platelet_mature\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	IL12RB1 GATA1 MCTP1 NBEAL2 IL21R TAL1 NPAS4	6.06e-06	180	170	7	4e9e8cde2919610c4ac0025b1c9819808048bc1d
ToppCell	E18.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	IL12RB1 GATA1 MCTP1 NBEAL2 IL21R TAL1 NPAS4	6.06e-06	180	170	7	466381bf93c3da6a2a241daadb68e9aad2964eae
ToppCell	pdx\|World / Sample and Cell Type and Tumor Cluster (all cells)	KIF26B SIPA1L3 GPATCH8 TBCK PUM1 NFAT5 MAML3	7.51e-06	186	170	7	de8e538c8767d41b8a52f5e58ba1affd4e7244c4
ToppCell	pdx-Tumor_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	KIF26B SIPA1L3 GPATCH8 TBCK PUM1 NFAT5 MAML3	7.51e-06	186	170	7	0b88a87158a9ca8de3bf40a4ff1687150707a5f0
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	HSPG2 SHROOM3 SH3RF1 NBEAL2 TMC5 USP6NL MYO16	8.05e-06	188	170	7	43a3a59f92ad93509d4166bd025aed0b1b39a008
ToppCell	CD8+_Memory_T_cell-CV-7\|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster	KIF13B MYCBP2 AHCTF1 MCM4 URB1 TBCK NFAT5	8.93e-06	191	170	7	9454f642c3621370fa23640b631301346b300950
ToppCell	COVID-19-lung-Secretory\|COVID-19 / Disease (COVID-19 only), tissue and cell type	DSC3 GRHL1 TP63 PLCH2 SPDEF TMC5 CDH3	9.23e-06	192	170	7	59261098ccb52306f837f632ebaea45b90ad30fe
ToppCell	BL-critical-LOC-Epithelial-Basal\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	DSC3 EFS NFIB TP63 SPDEF CDH3 RBFOX2	9.88e-06	194	170	7	2932f704656ca368565ec12f3452af3b18e8df12
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	KIF13B SHROOM3 NAALADL2 NOL4L NFIB NBEAL2 TMC5	9.88e-06	194	170	7	69bff17df4a760ccf081cf52ff04af02c14f448d
ToppCell	10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-osteoblast_precursor\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	EFS VGLL2 HOXA11 NFIB TMEM150C CDH15 RBFOX2	1.02e-05	195	170	7	ec12cfb2fce44cc2de4e198ef5af075e626f0329
ToppCell	Bronchial-NucSeq\|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations	SHROOM3 CLASP1 SIPA1L3 NAALADL2 ATXN1 MAML3 RBFOX2	1.06e-05	196	170	7	ab53c742866945545a92e2e61850d63c80d9a2a6
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_airway_basal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DSC3 EFS FER1L6 GRHL1 TP63 PLCH2 CDH3	1.09e-05	197	170	7	107cb153ea7fc74bbd244dbb9d0499c0a8506724
ToppCell	Transverse-(5)_Dendritic_cell-(53)_Lymphoid_DC\|Transverse / shred on region, Cell_type, and subtype	DNHD1 BCR SLCO5A1 SIDT2 TMEM150C MERTK PLD4	1.09e-05	197	170	7	15b87fd3906d7388c271d30d0c64b1bcc490801c
ToppCell	Transverse-Dendritic_cell-Lymphoid_DC\|Transverse / Region, Cell class and subclass	DNHD1 BCR SLCO5A1 SIDT2 TMEM150C MERTK PLD4	1.09e-05	197	170	7	a58af0ea82f76f2a7abac1f62629ff20d552fc63
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Goblet\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SUSD4 KIF26B FER1L6 GRHL1 GLI2 TMEM150C SPDEF	1.13e-05	198	170	7	af07a970afaa435c6433bb5c1cbff4c67af350c7
ToppCell	Biopsy_Control_(H.)-Epithelial-Basal\|Biopsy_Control_(H.) / Sample group, Lineage and Cell type	DSC3 PPP1R13L ASCL3 TP63 CDH3 CDH7 CNTN1	1.17e-05	199	170	7	6a274a5db02c55bbf31d602b9d5c8394241acdca
ToppCell	Macroglial-Polydendrocytes-PDGFRA-\|Macroglial / cells hierarchy compared to all cells using T-Statistic	SUSD4 KIF26B PLPPR5 CSMD2 MAP3K1 MCTP1 MYO16	1.20e-05	200	170	7	f17b5a54e8f9eba9dcd0808ba4e8d275ac41bce2
ToppCell	Macroglial-Polydendrocytes-PDGFRA--\|Macroglial / cells hierarchy compared to all cells using T-Statistic	SUSD4 KIF26B PLPPR5 CSMD2 MAP3K1 MCTP1 MYO16	1.20e-05	200	170	7	cc3409518f8b436ea92deb955e81114b3f410ff7
ToppCell	Bronchial_Brush-Epithelial-Basal_2\|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X	FLNA SUSD4 DSC3 PPP1R13L TP63 TACC1 CDH3	1.20e-05	200	170	7	7595eb2a8af3de879ecaa71f3d96f890e13b59ce
ToppCell	Macroglial-Polydendrocytes-PDGFRA\|Macroglial / cells hierarchy compared to all cells using T-Statistic	SUSD4 KIF26B PLPPR5 CSMD2 MAP3K1 MCTP1 MYO16	1.20e-05	200	170	7	c24a3099e3d96d8b72f6d05286bb355d661a0377
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW09-Neuronal-Cortical_neuron\|GW09 / Sample Type, Dataset, Time_group, and Cell type.	CTTNBP2 RTN1 NDFIP1 AMER2 NFIB RBFOX2 CNTN1	1.20e-05	200	170	7	44bc4d6616fc8d0ad8498e56125939034e8cff01
ToppCell	Non-neuronal-Dividing-IPC-IPC-div2\|World / Primary Cells by Cluster	FOXM1 NEUROD4 MCM4 PKMYT1 NEUROG1 NFIC POLD3	1.20e-05	200	170	7	4923d7a4f00853c4d76fc1cc0fa82d522a2302e7
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW10-Neuronal-Cortical_neuron\|GW10 / Sample Type, Dataset, Time_group, and Cell type.	CTTNBP2 RTN1 NDFIP1 AMER2 NFIB RBFOX2 CNTN1	1.20e-05	200	170	7	458fb0f40c1720f1cacedf78c40bd059692bfc62
ToppCell	Macroglial-Polydendrocytes-PDGFRA---\|Macroglial / cells hierarchy compared to all cells using T-Statistic	SUSD4 KIF26B PLPPR5 CSMD2 MAP3K1 MCTP1 MYO16	1.20e-05	200	170	7	4fc3de4bff7ed2bf40b38462c4b4e9b87af6a4ca
ToppCell	Non-neuronal-Dividing-IPC-IPC-div2-5\|World / Primary Cells by Cluster	FOXM1 NEUROD4 MCM4 PKMYT1 NEUROG1 NFIC POLD3	1.20e-05	200	170	7	dc1c1506823eaa105f1532c6b5d4efa14e788314
ToppCell	Macroglial-Polydendrocytes-PDGFRA----L1-6\|Macroglial / cells hierarchy compared to all cells using T-Statistic	SUSD4 KIF26B PLPPR5 CSMD2 MAP3K1 MCTP1 MYO16	1.20e-05	200	170	7	310cd53db1c137f6af74e6ae682221d7ac27310c
ToppCell	Macroglial-Polydendrocytes\|Macroglial / cells hierarchy compared to all cells using T-Statistic	SUSD4 KIF26B PLPPR5 CSMD2 MAP3K1 MCTP1 MYO16	1.20e-05	200	170	7	961858738ce35db8760c8c2e136f8369bc444ccf
ToppCell	facs-Liver-Liver_non-hepato/SCs_st-18m-Myeloid-myeloid_leukocyte\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLNA NLRP1 IRF5 RTN1 NACAD PLD4	3.37e-05	159	170	6	cdbccb83af6220bab300dfe56443ff69f6e2043a
ToppCell	Basal_cells-IPF_04\|World / lung cells shred on cell class, cell subclass, sample id	FOXM1 WEE1 NACAD AHDC1 NFIB TP63	3.87e-05	163	170	6	679e25e5548d157d49a73057a3b5617dccda260f
ToppCell	Children_(3_yrs)-Immune-enucleated_erythrocyte-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	NEU4 WRNIP1 AAAS YIF1B GLI2 MCF2L	4.58e-05	168	170	6	8f0c4dfad9f6fed9dcc31795abfe77758ceb46a1
ToppCell	Control\|World / group, cell type (main and fine annotations)	SHROOM3 SH3RF1 CACNA2D2 NAALADL2 DMBT1 TMC5	4.58e-05	168	170	6	a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6
ToppCell	Fetal_29-31_weeks-Epithelial-basal_cell-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	GRHL1 TP63 PLCH2 TMEM150C CDH7 VSIG10L2	4.58e-05	168	170	6	6521bead9789d626b86cbd08692c621c5a5aef33
ToppCell	Fetal_29-31_weeks-Epithelial-basal_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	GRHL1 TP63 PLCH2 TMEM150C CDH7 VSIG10L2	4.74e-05	169	170	6	c3ee781735a9288ce1822b230d39bb91c1415589
ToppCell	facs-Large_Intestine-Distal-18m-Epithelial-epithelial_cell_of_large_intestine\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FOXM1 HSPG2 HIRIP3 WEE1 HOXA6 HOXA11	5.40e-05	173	170	6	a5172dee859bf6c2eed46c48bd64dfef0ff9f28f
ToppCell	facs-Large_Intestine-Distal-18m-Epithelial-Lgr5-_amplifying_undifferentiated_cell\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FOXM1 HSPG2 HIRIP3 WEE1 HOXA6 HOXA11	5.40e-05	173	170	6	639b5b0b33ce5aa0bc26363c059717012ddc14c0
ToppCell	facs-Skin-Anagen-24m-Epithelial-outer_bulge\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPG2 COL18A1 HOXB9 NFATC1 NFIB FBXO41	5.75e-05	175	170	6	5552ff1e13f931c8cd7780726c90b5609497a648
ToppCell	356C-Myeloid-Macrophage-FABP4+_Macrophage_3\|Macrophage / Donor, Lineage, Cell class and subclass (all cells)	HSPG2 COL18A1 BEND6 NFIB TMEM150C CDH3	5.94e-05	176	170	6	bfa1633e1b7a8a2f04d37fa07284fe9bc0199f46
ToppCell	nucseq-Epithelial-Epithelial_Airway-Secretory/RAS\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	SUSD4 FER1L6 GRHL1 URB1 SPDEF TMC5	6.13e-05	177	170	6	779ba86f53650772755b52460be03f18bb204e55
ToppCell	nucseq-Epithelial-Epithelial_Airway-Secretory/RAS-Secretory\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	SUSD4 FER1L6 GRHL1 URB1 SPDEF TMC5	6.13e-05	177	170	6	0f210cfb61b873c5fd77dc17eadf4d017306500e
ToppCell	PND14-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet-Megakaryocyte/Platelet_mature\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TMEM158 GATA1 MCTP1 NBEAL2 TAL1 NPAS4	6.32e-05	178	170	6	63f5880a5b514e20ef2c07a6a9cb8df34e6cede5
ToppCell	PND14-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TMEM158 GATA1 MCTP1 NBEAL2 TAL1 NPAS4	6.32e-05	178	170	6	82c84f8b8a7e6a3d3be3351b348a37143279c100
ToppCell	PND10-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet-Megakaryocyte/Platelet_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TMEM158 GATA1 MCTP1 NBEAL2 TAL1 NPAS4	6.32e-05	178	170	6	9e1f2596fcea5b79cc50b58d83706bb8605e224f
ToppCell	PND10-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TMEM158 GATA1 MCTP1 NBEAL2 TAL1 NPAS4	6.32e-05	178	170	6	aa659bd283c4dfbe292cd8698bbf6b1999ca3314
ToppCell	PND10-Immune-Immune_Myeloid-Megakaryocyte/Platelet\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TMEM158 GATA1 MCTP1 NBEAL2 TAL1 NPAS4	6.32e-05	178	170	6	bf1d273802a4f42e52ea1bd2a0cae2039559c093
ToppCell	PND14-Immune-Immune_Myeloid-Megakaryocyte/Platelet\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TMEM158 GATA1 MCTP1 NBEAL2 TAL1 NPAS4	6.32e-05	178	170	6	cb91558469ae0748106fb0b6d702edb0ff21a884
ToppCell	facs-Brain_Non-Myeloid-Striatum_-18m-Macroglial-oligodendrocyte_precursor_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NEU4 SUSD4 PLPPR5 RTN1 ACAN CNTN1	6.72e-05	180	170	6	fa819df81fca95c2cc602fede635cb03e3f35fad
ToppCell	facs-Brain_Non-Myeloid-Striatum_-18m-Macroglial-Oligodendrocyte_progenitor_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NEU4 SUSD4 PLPPR5 RTN1 ACAN CNTN1	6.72e-05	180	170	6	907cd510fd2e21532ce04ba687e8894f7af71f27
ToppCell	wk_15-18-Epithelial-Proximal_epithelial-basal_late\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	MYOM3 PPP1R13L GRHL1 TP63 TMEM150C CDH3	6.72e-05	180	170	6	255097d8eb244a32eb2ecd0e7e48e1a20bafb5cd
ToppCell	critical-Myeloid-Mast_cell\|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	HSPG2 CTTNBP2 CACNA2D2 GATA1 TAL1 WNK3	6.93e-05	181	170	6	f0d81ae74d3f32979624a94b2ef93774831a7970
ToppCell	356C-Lymphocytic-CD4_T-cell-Proliferating_T_cell\|356C / Donor, Lineage, Cell class and subclass (all cells)	FOXM1 GATA1 MCM4 PKMYT1 TAL1 CDH7	6.93e-05	181	170	6	be4f35c9eb5b3083acb2264128f095fac1f3da45
ToppCell	Children_(3_yrs)-Epithelial-lung_goblet_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SUSD4 NAALADL2 FER1L6 GRHL1 TMEM150C TMC5	7.15e-05	182	170	6	3f1a666fe27dd7529c114539ed5f6b8ca585c875
ToppCell	Basal\|World / shred by cell class for mouse tongue	NOP53 RPS6KA1 SIPA1L3 COL18A1 TP63 CDH3	7.37e-05	183	170	6	c6729a207526ff4aa48176207b9353176f631fea
ToppCell	Epithelial-lung_goblet_cell\|World / Lineage, Cell type, age group and donor	SUSD4 FER1L6 GRHL1 TMEM150C SPDEF TMC5	7.37e-05	183	170	6	940cbe298e9c53b5622af09264586ed823d3141f
ToppCell	3'_v3-lymph-node_spleen-Mast\|lymph-node_spleen / Manually curated celltypes from each tissue	HSPG2 CTTNBP2 GATA1 TMEM150C TAL1 WNK3	7.59e-05	184	170	6	83675c7a083c52fb74dc8b9d35df0ef69715f707
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SUSD4 WEE1 NAALADL2 HOXD3 CDH3 CNTN1	7.59e-05	184	170	6	d33de57876817050b294f2ecb0a4eb0634cfa7f0
ToppCell	3'_v3-lymph-node_spleen-Mast-Mast_cells\|lymph-node_spleen / Manually curated celltypes from each tissue	HSPG2 CTTNBP2 GATA1 TMEM150C TAL1 WNK3	7.59e-05	184	170	6	ed266bd2d12f86e8786473e64fbcd58319cd4c2a
ToppCell	3'-Child04-06-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)\|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FLNA MASP1 NACAD DACT3 VSIG10L2 FAM131B	7.59e-05	184	170	6	590fb32bb1f348ea5fa2aece30ebe1e212512991
ToppCell	Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_granulocytic-mast_cell\|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	KIF13B CTTNBP2 GATA1 TAL1 MAML3 WNK3	7.82e-05	185	170	6	3fafb1d36c5f98a29d20a5ce5192c83d6f603514
ToppCell	Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_granulocytic\|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	KIF13B CTTNBP2 GATA1 TAL1 MAML3 WNK3	8.06e-05	186	170	6	de55471dd5c842026b409cfebf67fe32f079a011
ToppCell	droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	HSPG2 CLASP1 TMEM158 PPP1R13L BCR COL18A1	8.06e-05	186	170	6	c116cc9f41971622264434ebe29d18e719b0ae19
ToppCell	CV-Moderate-7\|CV / Virus stimulation, Condition and Cluster	CLASP1 MYCBP2 AHCTF1 MCM4 URB1 NFAT5	8.06e-05	186	170	6	8571956890fc9894d766ba294a28e376b4aba428
ToppCell	10x5'-Lung-Mast\|Lung / Manually curated celltypes from each tissue	HSPG2 CTTNBP2 GATA1 COL18A1 TAL1 WNK3	8.30e-05	187	170	6	f8ac5ca5cbe9c6f3d8c0fffc20fe08ca1aea43c0
ToppCell	10x5'-Lung-Mast-Mast_cells\|Lung / Manually curated celltypes from each tissue	HSPG2 CTTNBP2 GATA1 COL18A1 TAL1 WNK3	8.30e-05	187	170	6	da275d2c774b3e6a8ed77f777dd0676ecf2ddd2c
ToppCell	facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-interneuron\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA2D2 KIF26B RTN1 MCTP1 PLCH2 CDH15	8.30e-05	187	170	6	1b2fdbfb1ce3f19795dfc4b1da5a94f4b057ec41
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	HSPG2 SHROOM3 SH3RF1 NBEAL2 TMC5 MYO16	8.54e-05	188	170	6	eea652bab161f19148a883e7e3fe2523b36b3cea
ToppCell	TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Lobular_Carcinoma-6\|TCGA-Breast / Sample_Type by Project: Shred V9	KIF13B STARD8 MCTP1 GLI2 DACT3 PLD4	8.54e-05	188	170	6	c90669b51e1902fe7726555290c91c92a911df83
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FLNA SLCO5A1 GLI2 ACAN DACT3 NPAS4	8.80e-05	189	170	6	127ad2ba3e794df8cce2eee3e4171bccb5aad51b
ToppCell	COVID-19-Heart-EC_1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	HSPG2 WT1 MCTP1 NFIB TACC1 MCF2L	8.80e-05	189	170	6	fe49852ba15f948b384d6b4c258927c70b741357
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FLNA SLCO5A1 GLI2 ACAN DACT3 NPAS4	8.80e-05	189	170	6	2cfb4d12f75678d1619f4743838a0e954bd57761
ToppCell	facs-Aorta-Heart-3m-Mesenchymal-leukocyte\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLCO5A1 ACAN TP63 PLCH2 IL21R CDH3	9.32e-05	191	170	6	116fba9badea093e11f370996247cca0e4c02e8f
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-3_mon-IPC_like\|3_mon / Sample Type, Dataset, Time_group, and Cell type.	ZNF219 EFS NEUROD4 TMEM158 SLCO5A1 NEUROG1	9.32e-05	191	170	6	48cffb55c71bb8b34e926fc461fcd345ce43ea00
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-3_mon-IPC_like-IPCs\|3_mon / Sample Type, Dataset, Time_group, and Cell type.	ZNF219 EFS NEUROD4 TMEM158 SLCO5A1 NEUROG1	9.32e-05	191	170	6	e4c1c533771b582e21683dbec6f93a558d865e00
ToppCell	nucseq\|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ATXN1 ANKRD11 SIK2 NFAT5 MAML3 RBFOX2	9.87e-05	193	170	6	779276e775cb2492e8dd36436295a536084a6415
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-IPC_like-IPCs\|3.5_mon / Sample Type, Dataset, Time_group, and Cell type.	EFS KIF26B NEUROD4 TMEM158 SLCO5A1 NEUROG1	9.87e-05	193	170	6	2088f1d210c73f74685492c63065c62ac3f553e9
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-IPC_like\|3.5_mon / Sample Type, Dataset, Time_group, and Cell type.	EFS KIF26B NEUROD4 TMEM158 SLCO5A1 NEUROG1	9.87e-05	193	170	6	f24bae40f5cbcfece04fbefe4e3de1b88ac90de4
ToppCell	3'-GW_trimst-2-LargeIntestine-Epithelial\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NEU4 SHROOM3 CDHR2 HOXA13 HOXB9 TMC5	1.02e-04	194	170	6	07d8e38cbc2c7f0564c14f7c365f345f901b73b2
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	KIF13B SHROOM3 NAALADL2 NOL4L NBEAL2 TMC5	1.02e-04	194	170	6	04bfc555743f7d8821439d05ae442d15e9886c59
ToppCell	3'_v3-Lung-Mast\|Lung / Manually curated celltypes from each tissue	HSPG2 CTTNBP2 GATA1 COL18A1 TAL1 WNK3	1.02e-04	194	170	6	5e6eb81ddc9d5e22c1297734689f476d5a05bff6
ToppCell	3'_v3-Lung-Mast-Mast_cells\|Lung / Manually curated celltypes from each tissue	HSPG2 CTTNBP2 GATA1 COL18A1 TAL1 WNK3	1.02e-04	194	170	6	7b7f1714c4a9d9519c4d0e460cb87f2eb82392dd
ToppCell	18-Airway-Epithelial-Secretory_progenitor\|Airway / Age, Tissue, Lineage and Cell class	SUSD4 CTTNBP2 GRHL1 TMEM150C SPDEF TMC5	1.02e-04	194	170	6	9a2efa50731135a178141aae55fa8b3e022c9904
ToppCell	facs-Skin-Anagen-3m-Epithelial-outer_bulge\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPART MAP3K1 COL18A1 HOXB9 NFATC1 NFIB	1.02e-04	194	170	6	5d30d3d41d5f19cdf3077cc609aa2738762cb8c5
ToppCell	3'-Adult-Appendix-Endothelial-blood_vessel_EC-Mature_venous_EC\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	APBA3 BCR COL18A1 MANEAL TACC1 PIP4P2	1.04e-04	195	170	6	6a0460d949ccda7c9fe76870d3ee6c2f60677d61
ToppCell	Parenchymal-10x3prime_v2-Epithelial-Epi_airway_secretory-Secretory_Club\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	SHROOM3 SUSD4 GRHL1 SPDEF TMC5 CDH3	1.04e-04	195	170	6	b9e8f405f6d837bb39b615836d3e2df349737c0e
ToppCell	Bronchial-NucSeq-Epithelial-Epi_airway_secretory\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SHROOM3 SUSD4 FER1L6 GRHL1 TMC5 CDH3	1.04e-04	195	170	6	e7230a849ea31e6eef9bc6f5468938499450582d
ToppCell	5'-GW_trimst-2-LargeIntestine\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NEU4 HOXA11 HOXA13 HOXB9 HOXD3 SPDEF	1.04e-04	195	170	6	1a4a5623fa0318ef388cc228c7060e0586a7acf9
ToppCell	367C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	FOXM1 WEE1 MCM4 PKMYT1 SASS6 POLD3	1.07e-04	196	170	6	9591a6a3477ed6a1e2e016f7542e38603d8b16cb
ToppCell	Children_(3_yrs)-Immune-monocyte\|Children_(3_yrs) / Lineage, Cell type, age group and donor	NLRP1 RTN1 MAP3K1 MCTP1 MERTK MAML3	1.07e-04	196	170	6	cacd69be72e6167814f7adea7c5fa114f3103bbb
ToppCell	5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FOXM1 DSC3 PPP1R13L PKMYT1 TP63 CDH3	1.10e-04	197	170	6	fb272c9c60ee3d980e528044dc567b4925a23da6
ToppCell	Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-Myoepithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	FLNA DSC3 TP63 TACC1 CDH3 CNTN1	1.10e-04	197	170	6	f0475ad9c09c6da418dba17d3d3c1aaa2ef9ab4e
ToppCell	5'-Airway_Nasal-Epithelial-Airway_epithelium\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FOXM1 DSC3 PPP1R13L PKMYT1 TP63 CDH3	1.10e-04	197	170	6	61c0d78b29dc4ad8a84172cbfcdab03f31351d0e
Drug	LY294002; Up 200; 10uM; PC3; HT_HG-U133A	ZDHHC3 MAPK8IP3 HOXA6 URB1 YIF1B MCTP1 WIZ ATXN1 IRS2 MERTK	1.33e-06	189	166	10	5942_UP
Drug	prochlorperazine dimaleate salt; Up 200; 10uM; MCF7; HG-U133A	ATXN2L TCF3 GPATCH8 MAP3K1 COL18A1 SIDT2 BAZ2A NFIB IRS2 TAL1	1.60e-06	193	166	10	455_UP
Drug	rosiglitazone maleate; Down 200; 10uM; PC3; HG-U133A	STARD8 HIRIP3 NEUROD4 GATA1 AHDC1 SNX19 WIZ ATXN1 BAZ2A CWF19L1	1.68e-06	194	166	10	430_DN
Drug	Clidinium bromide [3485-62-9]; Down 200; 9.2uM; PC3; HT_HG-U133A	TCF3 CDHR2 SIPA1L3 MAPK8IP3 HOXA6 URB1 SIDT2 AAAS WIZ GLI2	1.93e-06	197	166	10	4499_DN
Drug	(+/-)-thalidomide; Down 200; 100uM; MCF7; HG-U133A	ATXN2L IL12RB1 MASP1 STARD8 EFS GATA1 HOXA6 NFATC1 TP63 IRS2	2.02e-06	198	166	10	266_DN
Drug	dimethyloxalylglycine; Up 200; 1000uM; PC3; HG-U133A	MASP1 ZNF219 SPART SNX19 SIDT2 BAZ2A FBXO42 SIK2 MCF2L	4.98e-06	172	166	9	584_UP
Drug	ICI 182,780; Down 200; 0.01uM; PC3; HT_HG-U133A	ATXN2L TCF3 APBA3 MAPK8IP3 HOXB9 WIZ NFATC1 CWF19L1 CNTN1	1.21e-05	192	166	9	4462_DN
Drug	LY 294002; Up 200; 10uM; PC3; HT_HG-U133A	WEE1 MAPK8IP3 COL18A1 ATXN1 ACAN SIK2 MERTK MCF2L PIGO	1.32e-05	194	166	9	1239_UP
Drug	Dropropizine (R,S) [17692-31-8]; Up 200; 17uM; MCF7; HT_HG-U133A	HSPG2 DSC3 SIDT2 WIZ BAZ2A NBEAL2 IRS2 MERTK MCF2L	1.32e-05	194	166	9	5531_UP
Drug	Azlocillin sodium salt [37091-65-9]; Down 200; 8.2uM; MCF7; HT_HG-U133A	KIF13B SUSD4 SIPA1L3 SPART IRF5 MAP3K1 ATXN1 NBEAL2 NFAT5	1.43e-05	196	166	9	3468_DN
Drug	Methiazole; Down 200; 15uM; PC3; HT_HG-U133A	HSPG2 ANKMY1 AHDC1 WIZ BAZ2A NBEAL2 CDH7 CWF19L1 PIGO	1.49e-05	197	166	9	4532_DN
Drug	rofecoxib; Down 200; 10uM; HL60; HG-U133A	MASP1 TCF3 GPATCH8 AHDC1 SNX19 AAAS TP63 ANKRD11 RBFOX2	1.49e-05	197	166	9	371_DN
Drug	trifluoperazine dihydrochloride; Down 200; 10uM; PC3; HT_HG-U133A	ATXN2L IL12RB1 ZNF219 WT1 URB1 WIZ NFIB CWF19L1 CNTN1	1.55e-05	198	166	9	4448_DN
Drug	Minaprine dihydrochloride [25953-17-7]; Up 200; 10.8uM; PC3; HT_HG-U133A	ATXN2L HSPG2 MASP1 KIF26B HOXA6 BAZ2A ACAN MCF2L TBX6	1.55e-05	198	166	9	4230_UP
Drug	Solasodine [126-17-0]; Up 200; 9.6uM; HL60; HT_HG-U133A	SUSD4 CACNA2D2 SIPA1L3 APBA3 MAP3K1 MAPK8IP3 FBXO41 SPDEF TBX6	1.55e-05	198	166	9	2170_UP
Drug	Azlocillin sodium salt [37091-65-9]; Up 200; 8.2uM; PC3; HT_HG-U133A	ATXN2L WRNIP1 WT1 IRF5 YIF1B BAZ2A ACAN IL21R MARK2	1.55e-05	198	166	9	5788_UP
Drug	Sulfamethoxazole [723-46-6]; Down 200; 15.8uM; PC3; HT_HG-U133A	HSPG2 DSC3 APBA3 AHDC1 NFATC1 NBEAL2 MARK2 CDH7 CWF19L1	1.55e-05	198	166	9	7366_DN
Drug	raloxifene hydrochloride; Down 200; 0.1uM; ssMCF7; HG-U133A	SUSD4 GPATCH8 AHDC1 SIDT2 NFIC ACAN FBXO41 DMBT1 PIGO	1.55e-05	198	166	9	376_DN
Drug	nordihydroguaiaretic acid; Down 200; 1uM; HL60; HT_HG-U133A	IL12RB1 DSC3 SIPA1L3 AHDC1 MAP3K1 MAPK8IP3 URB1 PIGO RBFOX2	1.61e-05	199	166	9	2683_DN
Drug	Resveratrol [501-36-0]; Up 200; 17.6uM; MCF7; HT_HG-U133A	NEUROD4 TICAM1 HOXA11 HOXB9 BAZ2A MARK2 MCF2L TAL1 CNTN1	1.61e-05	199	166	9	5509_UP
Drug	Strophanthidin [66-28-4]; Up 200; 9.8uM; MCF7; HT_HG-U133A	ATXN2L WEE1 NFIB ACAN IRS2 PUM1 NFAT5 MAML3	3.34e-05	168	166	8	6087_UP
Drug	CI-1031	MARK2 RBFOX2 CNTN1	6.02e-05	11	166	3	CID005353802
Drug	Triamcinolone [124-94-7]; Up 200; 10.2uM; HL60; HG-U133A	WEE1 BAZ2A EGR4 NBEAL2 TP63 BRD9 IRS2 NFAT5	7.39e-05	188	166	8	1395_UP
Drug	Fenoprofen calcium salt dihydrate [53746-45-5]; Up 200; 7.2uM; PC3; HT_HG-U133A	ATXN2L HSPG2 HOXA6 WIZ IL21R FBXO41 MCF2L TAL1	7.96e-05	190	166	8	4274_UP
Drug	Ethynodiol diacetate [297-76-7]; Down 200; 10.4uM; MCF7; HT_HG-U133A	KIF13B ZNF219 SETD1B SPART ANKMY1 WIZ SIK2 NFAT5	8.88e-05	193	166	8	5024_DN
Drug	(-) -Levobunolol hydrochloride [27912-14-7]; Down 200; 12.2uM; HL60; HT_HG-U133A	DSC3 CDHR2 SIPA1L3 NLRP1 BCR HOXA6 WIZ NFATC1	9.20e-05	194	166	8	3015_DN
Drug	CP-863187 [668981-07-5]; Down 200; 10uM; PC3; HT_HG-U133A	CDHR2 SIPA1L3 MANEA BCR URB1 BAZ2A CDH7 SEC23A	9.20e-05	194	166	8	7558_DN
Drug	Acebutolol hydrochloride [34381-68-5]; Up 200; 10.8uM; PC3; HG-U133A	HSPG2 HIRIP3 SIPA1L3 WIZ BAZ2A ACAN COASY SEC23A	9.54e-05	195	166	8	1911_UP
Drug	Xylazine [7361-61-7]; Down 200; 18.2uM; MCF7; HT_HG-U133A	TCF3 CDHR2 MAP3K1 WIZ BAZ2A NFIB SIK2 FBXO41	9.54e-05	195	166	8	4147_DN
Drug	Flurandrenolide [1524-88-5]; Up 200; 9.2uM; MCF7; HT_HG-U133A	ATXN2L MASP1 SIPA1L3 MAPK8IP3 CBLIF NEUROG1 FBXO41 DMBT1	9.54e-05	195	166	8	6039_UP
Drug	Levamisole hydrochloride [16595-80-5]; Up 200; 16.6uM; HL60; HG-U133A	TCF3 ANKMY1 AHDC1 WIZ BAZ2A NFE2L1 PLCH2 FBXO42	9.54e-05	195	166	8	1410_UP
Drug	Nizatidine [76963-41-2]; Down 200; 12uM; HL60; HT_HG-U133A	ATXN2L HSPG2 ZNF219 SIDT2 TP63 MARK2 TAL1 PIGO	9.54e-05	195	166	8	3047_DN
Drug	Theophylline monohydrate [5967-84-0]; Down 200; 20.2uM; MCF7; HT_HG-U133A	TCF3 ANKMY1 SIDT2 BAZ2A NFIB TACC1 USP6NL SEC23A	9.88e-05	196	166	8	4812_DN
Drug	Metyrapone [54-36-4]; Up 200; 17.6uM; HL60; HT_HG-U133A	KIF13B DSC3 PPP1R13L COL18A1 NFIB ACAN SPDEF TBX6	9.88e-05	196	166	8	3070_UP
Drug	Tinidazole [19387-91-8]; Up 200; 16.2uM; MCF7; HT_HG-U133A	CDHR2 TMEM158 CBLIF NFATC1 ACAN TP63 MAP3K10 MYO16	9.88e-05	196	166	8	4370_UP
Drug	CP-944629 [668990-94-1]; Up 200; 10uM; PC3; HT_HG-U133A	ATXN2L SIPA1L3 MCTP1 BAZ2A NFIB ACAN FBXO41 CWF19L1	9.88e-05	196	166	8	7502_UP
Drug	wortmannin from Penicillium funiculosum; Down 200; 0.01uM; PC3; HT_HG-U133A	IL12RB1 ZNF219 WT1 NLRP1 HOXA6 COL18A1 CDH7 CNTN1	9.88e-05	196	166	8	4467_DN
Drug	Phenindione [83-12-5]; Up 200; 18uM; HL60; HG-U133A	WT1 ANKMY1 SNX19 SIDT2 WIZ ACAN FBXO42 CNTN1	1.02e-04	197	166	8	1718_UP
Drug	Sulfadimethoxine [122-11-2]; Down 200; 12.8uM; MCF7; HT_HG-U133A	DSC3 CDHR2 NEUROD4 TMEM158 HOXA6 CBLIF NFIC TBX6	1.02e-04	197	166	8	4724_DN
Drug	Azapropazone [13539-59-8]; Up 200; 13.4uM; HL60; HT_HG-U133A	IL12RB1 ZNF219 KIF26B SPART APBA3 CBLIF SIDT2 EGR4	1.02e-04	197	166	8	3143_UP
Drug	Guaifenesin [93-14-1]; Down 200; 20.2uM; HL60; HT_HG-U133A	TCF3 CDHR2 APBA3 SIDT2 NFIC FBXO41 PIGO RBFOX2	1.02e-04	197	166	8	2569_DN
Drug	Niacin [59-67-6]; Down 200; 32.4uM; MCF7; HT_HG-U133A	KIF13B ZNF219 SIPA1L3 MAPK8IP3 WIZ BAZ2A FBXO42 FBXO41	1.02e-04	197	166	8	5301_DN
Drug	ICI182,780; Down 200; 1uM; PC3; HT_HG-U133A	ATXN2L ZNF219 SIPA1L3 MAPK8IP3 BAZ2A NFIB MCF2L PIGO	1.02e-04	197	166	8	6867_DN
Drug	Tolnaftate [2398-96-1]; Up 200; 13uM; MCF7; HT_HG-U133A	IL12RB1 CACNA2D2 AHDC1 MAP3K1 MAPK8IP3 YIF1B TACC1 NFAT5	1.02e-04	197	166	8	1501_UP
Drug	N-phenylanthranilic acid; Up 200; 10uM; MCF7; HG-U133A	ATXN2L ASCL3 SIDT2 NEUROG1 WIZ ACAN FBXO42 FBXO41	1.06e-04	198	166	8	317_UP
Drug	Testosterone propionate [57-85-2]; Up 200; 11.6uM; MCF7; HT_HG-U133A	ATXN2L TMEM158 AHDC1 MAPK8IP3 CBLIF SIDT2 NFIB PLCH2	1.06e-04	198	166	8	2649_UP
Drug	GSK-3 Inhibitor IX; Down 200; 0.5uM; PC3; HT_HG-U133A	CACNA2D2 MCM4 AAAS MCTP1 MERTK CWF19L1 FAM131B RBFOX2	1.06e-04	198	166	8	7048_DN
Drug	Homosalate [118-56-9]; Up 200; 15.2uM; PC3; HT_HG-U133A	IL12RB1 CDHR2 WRNIP1 MAPK8IP3 YIF1B TP63 IL21R TBX6	1.06e-04	198	166	8	3797_UP
Drug	Iopamidol [60166-93-0]; Down 200; 5.2uM; MCF7; HT_HG-U133A	TCF3 TICAM1 SIPA1L3 BAZ2A NFIB NFIC FBXO41 MCF2L	1.06e-04	198	166	8	7189_DN
Drug	Pizotifen malate [5189-11-7]; Up 200; 9.4uM; MCF7; HT_HG-U133A	KIF13B DSC3 WEE1 TICAM1 BCR MCTP1 ACAN IRS2	1.06e-04	198	166	8	5491_UP
Drug	estradiol, USP; Down 200; 0.01uM; HL60; HG-U133A	MASP1 SUSD4 DSC3 CACNA2D2 ZDHHC3 BAZ2A ACAN CWF19L1	1.06e-04	198	166	8	387_DN
Drug	9-deoxy-9-methylene-16,16-dimethyl Prostaglandin E2; Down 200; 10uM; PC3; HT_HG-U133A	CDHR2 SIPA1L3 APBA3 URB1 BAZ2A IRS2 SEC23A TBX6	1.06e-04	198	166	8	7557_DN
Drug	15(S)-15-methyl Prostaglandin E2; Down 200; 10uM; MCF7; HT_HG-U133A	HSPG2 ANKMY1 HOXA6 URB1 WIZ SIK2 FBXO41 IRS2	1.06e-04	198	166	8	7521_DN
Drug	Amitryptiline hydrochloride [549-18-8]; Down 200; 12.8uM; MCF7; HT_HG-U133A	GPATCH8 SIDT2 NFIB FBXO42 TACC1 MARK2 NFAT5 PIGO	1.06e-04	198	166	8	1701_DN
Drug	Griseofulvin [126-07-8]; Down 200; 11.2uM; PC3; HT_HG-U133A	HSPG2 MANEA COL18A1 AAAS ATXN1 BAZ2A FBXO42 CDH7	1.06e-04	198	166	8	7363_DN
Drug	Aceclofenac [89796-99-6]; Down 200; 11.2uM; PC3; HT_HG-U133A	HSPG2 TCF3 MAPK8IP3 HOXB9 SIDT2 AAAS ATXN1 DMBT1	1.06e-04	198	166	8	2117_DN
Drug	Napelline [5008-52-6]; Up 200; 11.2uM; PC3; HT_HG-U133A	ATXN2L TCF3 ZNF219 WT1 NLRP1 WIZ PLCH2 TBX6	1.06e-04	198	166	8	4486_UP
Drug	Sulfamerazine [127-79-7]; Down 200; 15.2uM; MCF7; HT_HG-U133A	TCF3 ZNF219 MAPK8IP3 BAZ2A TACC1 CWF19L1 PIGO RBFOX2	1.10e-04	199	166	8	6036_DN
Drug	Ebselen [60940-34-3]; Down 200; 14.6uM; HL60; HT_HG-U133A	IL12RB1 ZNF219 NEUROD4 NLRP1 MAP3K1 URB1 USP6NL PIGO	1.10e-04	199	166	8	2717_DN
Drug	genistein; Down 200; 1uM; MCF7; HG-U133A	ATXN2L IL12RB1 WIZ NFATC1 NFIB ACAN TP63 FBXO41	1.10e-04	199	166	8	267_DN
Drug	(R)-(+)-Atenolol [56715-13-0]; Down 200; 15uM; MCF7; HT_HG-U133A	KIF13B HSPG2 TCF3 ZNF219 SIPA1L3 NFIB TACC1 MERTK	1.10e-04	199	166	8	2855_DN
Drug	Dioxybenzone [131-53-3]; Up 200; 16.4uM; HL60; HT_HG-U133A	HSPG2 MASP1 ZNF219 PPP1R13L GLI2 IL21R SPDEF DMBT1	1.10e-04	199	166	8	3101_UP
Drug	Isoquinoline, 6,7-dimethoxy-1-methyl-1,2,3,4-tetrahydro, hydrochloride; Up 200; 16.4uM; MCF7; HT_HG-U133A	DSC3 CDHR2 NEUROD4 MAPK8IP3 HOXB9 YIF1B GLI2 TP63	1.10e-04	199	166	8	4810_UP
Drug	Diphenhydramine hydrochloride [147-24-0]; Up 200; 13.8uM; MCF7; HT_HG-U133A	STARD8 DSC3 MAPK8IP3 ACAN FBXO42 FBXO41 TACC1 MERTK	1.10e-04	199	166	8	6020_UP
Drug	Idazoxan hydrochloride [79944-56-2]; Down 200; 16.6uM; MCF7; HT_HG-U133A	KIF13B SIPA1L3 SNX19 AAAS MCTP1 BAZ2A IRS2 CWF19L1	1.10e-04	199	166	8	6465_DN
Drug	prostaglandin E2; Down 200; 10uM; PC3; HT_HG-U133A	HIRIP3 IRF5 HOXA11 MCTP1 WIZ PLCH2 SIK2 CNTN1	1.10e-04	199	166	8	6586_DN
Drug	Gabapentin [60142-96-3]; Down 200; 23.4uM; HL60; HT_HG-U133A	IL12RB1 SETD1B NLRP1 MAP3K1 WIZ NFATC1 TMC5 USP6NL	1.10e-04	199	166	8	2731_DN
Drug	Altretamine [654-05-6]; Up 200; 19uM; MCF7; HT_HG-U133A	MASP1 TMEM158 URB1 HOXB9 MCTP1 HOXD3 TP63 TBX6	1.10e-04	199	166	8	5688_UP
Drug	Trichlorfon [52-68-6]; Up 200; 15.6uM; PC3; HT_HG-U133A	ATXN2L HSPG2 NLRP1 ANKMY1 HOXA6 CBLIF NFATC1 PIGO	1.10e-04	199	166	8	7287_UP
Drug	Iproniazide phosphate [305-33-9]; Up 200; 14.4uM; HL60; HG-U133A	FOXM1 ATXN2L TCF3 CDHR2 SNX19 ERAP2 BAZ2A FBXO42	1.10e-04	199	166	8	1442_UP
Drug	Cefmetazole sodium salt [56796-39-5]; Up 200; 8.2uM; MCF7; HT_HG-U133A	DSC3 EFS CDHR2 EGR4 ACAN TP63 PIGO TBX6	1.14e-04	200	166	8	6086_UP
Drug	Iobenguane sulfate; Up 200; 10.8uM; MCF7; HT_HG-U133A	CDHR2 MAP3K1 CBLIF URB1 MCTP1 WIZ FBXO41 MERTK	1.14e-04	200	166	8	6002_UP
Drug	Strophanthidin [66-28-4]; Down 200; 9.8uM; MCF7; HT_HG-U133A	ZNF219 APBA3 AHDC1 SIDT2 ATXN1 BAZ2A MARK2 NFAT5	1.14e-04	200	166	8	7182_DN
Drug	Thonzonium bromide [553-08-2]; Up 200; 6.8uM; PC3; HT_HG-U133A	EFS ANKMY1 MAP3K1 SIDT2 HOXD3 ATXN1 IRS2	2.85e-04	173	166	7	4617_UP
Drug	Lanatoside C [17575-22-3]; Up 200; 4uM; MCF7; HT_HG-U133A	ATXN2L EFS WEE1 NLRP1 MAPK8IP3 IRS2 NFAT5	2.95e-04	174	166	7	6048_UP
Drug	ICI 182,780; Down 200; 1uM; MCF7; HT_HG-U133A_EA	ELOA MYCBP2 GPATCH8 ATXN1 NFIB NFIC ANKRD11	3.28e-04	177	166	7	985_DN
Drug	LY 294002; Up 200; 10uM; PC3; HT_HG-U133A	MASP1 CACNA2D2 MCTP1 WIZ ATXN1 IRS2 PUM1	4.42e-04	186	166	7	4463_UP
Drug	0297417-0002B [362658-29-5]; Up 200; 10uM; MCF7; HT_HG-U133A	KIF13B TCF3 APBA3 IRS2 MCF2L KDSR TBX6	4.56e-04	187	166	7	6902_UP
Drug	Hexetidine [141-94-6]; Up 200; 11.8uM; MCF7; HT_HG-U133A	TICAM1 MAPK8IP3 EGR4 TP63 IRS2 MARK2 TBX6	4.56e-04	187	166	7	5420_UP
Drug	genistein; Down 200; 10uM; HL60; HT_HG-U133A	SIPA1L3 IRF5 BCR WIZ BAZ2A BRD9 FBXO41	4.71e-04	188	166	7	1176_DN
Drug	Fluticasone propionate [80474-14-2]; Down 200; 8uM; HL60; HT_HG-U133A	TCF3 TMEM158 WT1 NLRP1 MAPK8IP3 NFATC1 PIGO	4.86e-04	189	166	7	2928_DN
Drug	Clomipramine hydrochloride [17321-77-6]; Up 200; 11.4uM; MCF7; HT_HG-U133A	EFS CDHR2 SPART MAPK8IP3 NFIB PLCH2 IRS2	5.01e-04	190	166	7	6825_UP
Drug	pioglitazone HCl; Up 200; 10uM; PC3; HT_HG-U133A	TCF3 TMEM158 WT1 SIK2 IRS2 DMBT1 CDH7	5.17e-04	191	166	7	7088_UP
Drug	Metergoline [17692-51-2]; Up 200; 10uM; MCF7; HT_HG-U133A	KIF13B APBA3 HOXB9 BAZ2A SIK2 IRS2 TMC5	5.17e-04	191	166	7	5344_UP
Drug	Drofenine hydrochloride [548-66-3]; Up 200; 11.4uM; MCF7; HT_HG-U133A	TCF3 TMEM158 TICAM1 MAPK8IP3 BAZ2A NFIB TP63	5.17e-04	191	166	7	6776_UP
Drug	Ald1.1-H_000455; Up 200; 10uM; MCF7; HT_HG-U133A	ATXN2L NEUROD4 MAPK8IP3 WIZ MERTK TMC5 PIGO	5.17e-04	191	166	7	7542_UP
Drug	Lasalocid sodium salt [25999-20-6]; Down 200; 6.6uM; PC3; HT_HG-U133A	ZNF219 CACNA2D2 SIPA1L3 MAPK8IP3 WIZ BAZ2A CWF19L1	5.34e-04	192	166	7	6639_DN
Drug	clozapine; Down 200; 10uM; HL60; HT_HG-U133A	ATXN2L ZNF219 SIPA1L3 BCR FBXO41 NFAT5 PIGO	5.34e-04	192	166	7	6188_DN
Drug	Pimozide [2062-78-4]; Up 200; 8.6uM; HL60; HG-U133A	SPART ANKMY1 EGR4 ACAN TP63 ANKRD11 SIK2	5.34e-04	192	166	7	1562_UP
Drug	Carbenoxolone disodium salt [7421-40-1]; Down 200; 6.6uM; MCF7; HT_HG-U133A	CACNA2D2 CDHR2 WIZ NFIB FBXO41 NFAT5 CWF19L1	5.50e-04	193	166	7	4173_DN
Drug	CP-690334-01 [459212-38-5]; Down 200; 10uM; MCF7; HT_HG-U133A	ELOA MCM4 IRF5 WIZ NFIC TMC5 NFAT5	5.50e-04	193	166	7	3906_DN
Drug	Sulpiride [15676-16-1]; Down 200; 11.8uM; PC3; HT_HG-U133A	WT1 MCM4 MCTP1 SEC24B USP6NL SEC23A RBFOX2	5.50e-04	193	166	7	4566_DN
Drug	Mexiletine hydrochloride [5370-01-4]; Down 200; 18.6uM; PC3; HT_HG-U133A	ATXN2L HSPG2 ZNF219 AHDC1 NFATC1 BAZ2A CDH3	5.50e-04	193	166	7	4338_DN
Drug	Vincamine [1617-90-9]; Up 200; 11.2uM; PC3; HT_HG-U133A	NLRP1 BAZ2A NFIB TP63 DMBT1 MCF2L NFAT5	5.50e-04	193	166	7	4341_UP
Drug	Nilutamide [63612-50-0]; Up 200; 12.6uM; MCF7; HT_HG-U133A	TCF3 RPS6KA1 APBA3 SIDT2 BAZ2A MARK2 CWF19L1	5.68e-04	194	166	7	5362_UP
Drug	Rapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A	KIF13B MAPK8IP3 SIDT2 YIF1B NFIB TMC5 PIGO	5.68e-04	194	166	7	7001_UP
Drug	Methoxy-8-psoralen [298-81-7]; Up 200; 18.6uM; MCF7; HT_HG-U133A	ATXN2L DSC3 TMEM158 IRF5 NFIB CWF19L1 CNTN1	5.68e-04	194	166	7	3302_UP
Drug	Nitrofurantoin [67-20-9]; Down 200; 16.8uM; PC3; HT_HG-U133A	ATXN2L CACNA2D2 APBA3 URB1 WIZ NFIB MCF2L	5.68e-04	194	166	7	3674_DN
Drug	Indomethacin [53-86-1]; Up 200; 11.2uM; HL60; HT_HG-U133A	DSC3 EFS SIPA1L3 PPP1R13L MAPK8IP3 HOXA6 NFAT5	5.68e-04	194	166	7	2377_UP
Drug	Clofilium tosylate [92953-10-1]; Down 200; 7.8uM; PC3; HT_HG-U133A	CACNA2D2 CDHR2 URB1 SIDT2 BAZ2A NBEAL2 TAL1	5.68e-04	194	166	7	4492_DN
Disease	Global developmental delay	CACNA2D2 KDM3B SPART MAPK8IP3 PRR12 NFIB PUM1	1.12e-05	133	167	7	C0557874
Disease	sleep duration	SH3RF1 MYCBP2 KDM3B PLPPR5 NAALADL2 RTN1 PRR12 TBCK TMC5 PUM1	4.39e-05	362	167	10	EFO_0005271
Disease	Female Urogenital Diseases	HOXA11 HOXA13 TP63	1.36e-04	18	167	3	C1720887
Disease	prostate carcinoma	SHROOM3 SH3RF1 SIPA1L3 POU5F1B GPATCH8 MAP3K1 GRHL1 NFIB SIK2 SPDEF TACC1 KDSR MAML3 MYO16 WNK3	1.75e-04	891	167	15	EFO_0001663
Disease	aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement	ATXN2L SNX19 HOXA13 NFIB ACAN COASY NFAT5 TAL1 MAML3	2.43e-04	364	167	9	EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946
Disease	arrhythmogenic right ventricular cardiomyopathy (implicated_via_orthology)	DSC3 PPP1R13L	3.15e-04	5	167	2	DOID:0050431 (implicated_via_orthology)
Disease	neuroimaging measurement	ATXN2L SHROOM3 CTTNBP2 EFS NDUFAF2 KIF26B RNF34 BCR MAP3K1 MAPK8IP3 COL18A1 AMER2 NFIB TP63 TMC5 MYO16	3.95e-04	1069	167	16	EFO_0004346
Disease	cutaneous melanoma, hair color	BCR MAP3K1 CDH3 CDH15	4.28e-04	62	167	4	EFO_0000389, EFO_0003924
Disease	Swyer Syndrome	WT1 MAP3K1	6.56e-04	7	167	2	C2936694
Disease	hyperuricemia	SIPA1L3 NFATC1 NFAT5	8.57e-04	33	167	3	EFO_0009104
Disease	Gonadal Dysgenesis, 46,XY	WT1 MAP3K1	8.72e-04	8	167	2	C0018054
Disease	LEUKEMIA, ACUTE LYMPHOBLASTIC	BCR TAL1	8.72e-04	8	167	2	613065
Disease	Acute lymphoid leukemia	BCR TAL1	8.72e-04	8	167	2	cv:C0023449
Disease	Kunitz-type protease inhibitor 2 measurement	SIPA1L3 YIF1B	1.39e-03	10	167	2	EFO_0008200
Disease	Sclerocystic Ovaries	NOP53 MANEA MAPK8IP3 DACT3 CDH15	1.40e-03	144	167	5	C1136382
Disease	Polycystic Ovary Syndrome	NOP53 MANEA MAPK8IP3 DACT3 CDH15	1.40e-03	144	167	5	C0032460
Disease	cortical surface area measurement	ATXN2L SHROOM3 CTTNBP2 MYCBP2 EFS NDUFAF2 KIF26B BCR MAP3K1 PKMYT1 NOL4L NFIB FBXO42 TACC1 POLD3 MYO16 TBX6	1.68e-03	1345	167	17	EFO_0010736
Disease	46,XY partial gonadal dysgenesis	WT1 MAP3K1	1.69e-03	11	167	2	C4510744
Disease	FEV/FEC ratio	HSPG2 CTTNBP2 MAP3K1 SLCO5A1 PRR12 NOL4L HOXD3 NFATC1 NFIC ACAN TBCK ANKRD11 DMBT1 LRRC37B TAL1 MYO16	1.70e-03	1228	167	16	EFO_0004713
Disease	colorectal cancer, colorectal adenoma	POU5F1B NACAD POLD3 CDH3 CDH15	1.77e-03	152	167	5	EFO_0005406, MONDO_0005575
Disease	body fat percentage	ATXN2L SNX19 HOXA13 NFIB ACAN COASY NFAT5 TAL1 MAML3	1.93e-03	488	167	9	EFO_0007800
Disease	autosomal dominant cerebellar ataxia (implicated_via_orthology)	ATXN2L ATXN1	2.02e-03	12	167	2	DOID:1441 (implicated_via_orthology)
Disease	mean platelet volume	STARD8 SETD1B PCDHGA4 ANKMY1 NOL4L YIF1B NFATC1 BAZ2A NFE2L1 ANKRD11 IRS2 MCF2L TAL1 TBX6	2.06e-03	1020	167	14	EFO_0004584
Disease	mean reticulocyte volume	CLASP1 RPS6KA1 WT1 MCM4 NOL4L IRS2 TAL1 CDH3 PIGO MYO16 CDH15 TBX6	2.06e-03	799	167	12	EFO_0010701
Disease	adipose tissue measurement	SH3RF1 TP63 MYO16	2.12e-03	45	167	3	EFO_0004764
Disease	hydroxy-leucine measurement	KIF13B SLCO5A1 CNTN1	2.12e-03	45	167	3	EFO_0005276
Disease	response to angiotensin-converting enzyme inhibitor, Cough	CLASP1 PKD1L2 NAALADL2	2.26e-03	46	167	3	EFO_0005325, HP_0012735
Disease	Adenoid Cystic Carcinoma	NFIB MARK2 MAML3 RBFOX2	2.55e-03	100	167	4	C0010606
Disease	hepatocellular carcinoma (implicated_via_orthology)	FOXM1 COL18A1 NFE2L1	2.71e-03	49	167	3	DOID:684 (implicated_via_orthology)
Disease	Pneumoconiosis	TICAM1 ACAN	2.77e-03	14	167	2	C0032273
Disease	Bagassosis	TICAM1 ACAN	2.77e-03	14	167	2	C0004681
Disease	complement factor H-related protein 3 measurement	SH3RF1 MANEA NFATC1 ACAN TP63	2.81e-03	169	167	5	EFO_0600056
Disease	L2 Acute Lymphoblastic Leukemia	TCF3 BCR TAL1	2.87e-03	50	167	3	C0023453
Disease	low density lipoprotein cholesterol measurement, response to selective serotonin reuptake inhibitor	CSMD2 USP6NL	3.19e-03	15	167	2	EFO_0004611, EFO_0005658
Disease	Squamous cell carcinoma of the head and neck	WEE1 TBCK MERTK	3.21e-03	52	167	3	C1168401
Disease	Childhood Acute Lymphoblastic Leukemia	TCF3 BCR TAL1	3.21e-03	52	167	3	C0023452
Disease	Spondyloepiphyseal Dysplasia	HSPG2 FLNA	3.63e-03	16	167	2	C0038015
Disease	Spondyloepiphyseal Dysplasia Tarda, X-Linked	HSPG2 FLNA	3.63e-03	16	167	2	C3541456
Disease	Schwartz-Jampel Syndrome, Type 1	HSPG2 FLNA	3.63e-03	16	167	2	C4551479
Disease	Abnormal behavior	KDM3B PRR12	3.63e-03	16	167	2	C0233514
Disease	Schwartz-Jampel Syndrome	HSPG2 FLNA	3.63e-03	16	167	2	C0036391
Disease	Melnick-Needles Syndrome	HSPG2 FLNA	3.63e-03	16	167	2	C0025237
Disease	leukemia	FOXM1 WT1 PPP1R13L	3.76e-03	55	167	3	C0023418
Disease	polyp of colon	POU5F1B CDH3 CDH15	3.96e-03	56	167	3	MONDO_0021400
Disease	Van Buchem disease	HSPG2 FLNA	4.10e-03	17	167	2	C0432272
Disease	Limb Deformities, Congenital	HOXA11 TP63	4.10e-03	17	167	2	C0206762
Disease	brain measurement, neuroimaging measurement	ATXN2L CTTNBP2 NDUFAF2 KIF26B GPATCH8 ASCL3 MAP3K1 COL18A1 MCTP1	4.25e-03	550	167	9	EFO_0004346, EFO_0004464
Disease	blood osmolality measurement	PKD1L2 NAALADL2 NFAT5	4.37e-03	58	167	3	EFO_0007967
Disease	maximum cigarettes per day measurement	NFATC1 TMC5	4.59e-03	18	167	2	EFO_0009264
Disease	Precursor Cell Lymphoblastic Leukemia Lymphoma	TCF3 BCR TAL1	5.04e-03	61	167	3	C1961102
Disease	osteochondrodysplasia (is_implicated_in)	HSPG2 FLNA	5.11e-03	19	167	2	DOID:2256 (is_implicated_in)
Disease	Osteochondrodysplasias	HSPG2 FLNA	5.11e-03	19	167	2	C0029422
Disease	Dyschondroplasias	HSPG2 FLNA	5.11e-03	19	167	2	C0013366
Disease	leukemia (implicated_via_orthology)	HOXA6 MEIS3P2	5.11e-03	19	167	2	DOID:1240 (implicated_via_orthology)
Disease	Multiple Epiphyseal Dysplasia	HSPG2 FLNA	5.66e-03	20	167	2	C0026760
Disease	coagulation factor measurement	MCF2L CNTN1	5.66e-03	20	167	2	EFO_0004634
Disease	response to heparin, antibody measurement	NDUFAF2 NAALADL2	5.66e-03	20	167	2	EFO_0004556, EFO_0006816

Protein segments in the cluster

Peptide	Gene	Start	Entry
SPPLSSEGSYHFDPD	TACC1	406	O75410
VTGSSYESPPPDFRG	AAAS	26	Q9NRG9
PSAFYSPPHNGLLTD	AKAP2	26	Q9Y2D5
YDLYADPDGSPATLP	AMER2	556	Q8N7J2
HSAAPGPFSASEAPY	ANKRD11	2001	Q6UB99
SEAAPYAPPSGLESF	ANKRD11	2051	Q6UB99
SSGTILSPGFPDFYP	CSMD2	931	Q7Z408
LPLLAAPGASAYSFP	CACNA2D2	51	Q9NY47
DPYEFLQSPEPAASA	BRD9	581	Q9H8M2
DGLPYIDDSPSSSPH	BCR	451	P11274
PAAGPRYSEEGLSPS	BAZ2A	1771	Q9UIF9
EPPAGAQSPETLASY	APBA3	186	O96018
LTEGDYVPDSPALSP	CDK11B	401	P21127
PGTSDLPAPADLTVY	DNHD1	4691	Q96M86
PAPPPGDLQYSFFSS	AHDC1	156	Q5TGY3
SEPLPVGLPATAFYA	ATXN1	441	P54253
AAFSPSPGFSPYNVS	DHRS4	171	Q9BTZ2
AAAAGPPLVAATPYS	ATXN2L	771	Q8WWM7
RDPYSGNAFLPGESS	BEND6	41	Q5SZJ8
SASEILYSAPPGDPL	NFE2L1	331	Q14494
LYSAPPGDPLSTNYS	NFE2L1	336	Q14494
TGDFYPSPSSPAAGS	NFIB	286	O00712
YTAGPQGSPLSDPDV	HSPG2	1421	P98160
PGFPYPTAATTAAAF	RBFOX2	266	O43251
PEILYPTFPTDGSTG	PCDHGA4	591	Q9Y5G9
ALYSSVPFPEGEVFP	POU5F1B	331	Q06416
QAISPSTPSAPEGYD	FBXO42	461	Q6P3S6
PLDFDVSSPLTYGTP	MCM4	81	P33991
AAFSPSPGFSPYNVS	DHRS4L2	171	Q6PKH6
AEAEDGGSSVPPSPY	MAP3K10	616	Q02779
PAVEVAPAGASYNPS	NOP53	236	Q9NZM5
ESGSEASSPDYFGPP	HIRIP3	101	Q9BW71
RPFPASYGASSLPDK	HOXA6	36	P31267
AAAGEPEPPAASSSF	MCTP1	6	Q6DN14
SSIPAASDSDYPPGE	MAPK8IP3	811	Q9UPT6
SPAASEDFTYRPGDP	NEUROG1	201	Q92886
LGPPSSPYGAAFTAE	MAML3	521	Q96JK9
SPYGAAFTAEKPNSP	MAML3	526	Q96JK9
VDYAPSSTPAPGNAD	MERTK	486	Q12866
VPDSGPEPILAFYSS	HIPK4	466	Q8NE63
DARKAGSSASPPAPY	MYO16	1646	Q9Y6X6
PDFPIAHLSSDPDYS	KIF26B	841	Q2KJY2
TESLNEPVPGYSFSP	CWF19L1	116	Q69YN2
EPVPGYSFSPKDVSS	CWF19L1	121	Q69YN2
SYAPPSGDPSIESTD	GPATCH8	1281	Q9UKJ3
GPEDSSAVPPVLLYS	PLPPR5	56	Q32ZL2
AQEGAGHSPSFPYSP	NLRP1	86	Q9C000
YDSNVFAESSRPGPP	COL18A1	1271	P39060
PPPADFAPEDYSSFQ	NFATC1	361	O95644
DEPVGGDTPASFTPY	KDM3B	371	Q7LBC6
GAPSGYSPKEFATPD	MYCLP1	111	P12525
FDAPPTYASTPDGED	LRRC14B	251	A6NHZ5
PAAPGDFDYLGPSAS	LRRC37B	66	Q96QE4
YPTESTGFSDNPRLP	GLI2	1086	P10070
DLYSPDLGAAPFPEA	EGR4	246	Q05215
APTDSQPPEDYSFGA	IRF5	126	Q13568
GLAYDAPSPPAFAKS	HOXD3	291	P31249
YVSGPDFSSLPSFLP	HOXA11	21	P31270
PPATALGTASYPSDG	NOL4L	96	Q96MY1
PSGYSDLASIGPAPE	NEU4	416	Q8WWR8
VQPFTYTPDPAAAGA	NFAT5	536	O94916
ATGSYLGPAFDDSQP	FAM131B	216	Q86XD5
PPDDIGSSFYPELGS	MANEA	146	Q5SRI9
YPEAGFGASAAPEAS	ACAN	2106	P16112
GDSHTFDPYNPPSVS	PKD1L2	291	Q7Z442
YPSIADGPAALAGFP	MEIS3P2	11	A8K0S8
ISAAPPGTDPYTAGL	PUM1	431	Q14671
YCDSFDPPTFPALGT	GBA	61	P04062
DPPTFPALGTFSRYE	GBA	66	P04062
EDAPPAKFPSGQYAS	HOXB9	21	P17482
FDGVPTTAYFSASPP	PLD4	296	Q96BZ4
PGALPPANTYASIDF	IRS2	1311	Q9Y4H2
GDAPPPYSSISAESA	NDFIP1	36	Q9BT67
ELDFSYLTFPSGPEP	NPAS4	396	Q8IUM7
YLTFPSGPEPSLQAE	NPAS4	401	Q8IUM7
PSNTDYPGPHSFDVS	TP63	166	Q9H3D4
LPVPNSAYGGPDFSS	GATA1	156	P15976
PGPYSHNFSLDPDTG	CDHR2	626	Q9BYE9
APSSPNAEASAFYGP	CBLIF	121	P27352
SSQLPPDGGAFYTPE	HEATR5B	1501	Q9P2D3
GPYGTEDDFAVPPST	GRHL1	506	Q9NZI5
AAVPRSFSAPYPTAG	DACT3	181	Q96B18
STADGYSADLPLPLP	DSC3	216	Q14574
FNPSPEEPAYDGPST	ELOA	741	Q14241
SYGDLIGASVPAFPP	CTTNBP2	361	Q8WZ74
VDVTYDGSPVPSSPF	FLNA	1331	P21333
TEATLSFGYLDPFPP	CNTN1	126	Q12860
YYLDPDAPLSGPSTQ	CCDC66	856	A2RUB6
GPPQAYYSTDTALPE	ANKMY1	641	Q9P2S6
PFPSDSLILGNYSEP	ASCL3	56	Q9NQ33
RVPSSGPYDCPASFS	EFS	156	O43281
ASPASPSPADVAYEE	FBXO41	186	Q8TF61
FQDPPYPDADSGSAS	IL12RB1	31	P42701
PFGPDFYSSDTEEPA	MARVELD2	56	Q8N4S9
HSPPDDLGSSFYPEL	MANEAL	146	Q5VSG8
LDTFCGSPPYAAPEL	MARK2	206	Q7KZI7
IQSPGYPDSYPSDSE	MASP1	31	P48740
GSPVITFPDYPAFSE	MCF2L	91	O15068
PSSYHFTEDPGAFPV	ERAP2	41	Q6P179
PFPADSSDPASQLSY	FOXM1	576	Q08050
PPANGSYDSFFLAPE	KNDC1	501	Q76NI1
DFTSPGDEGPPRSYL	IL21R	506	Q9HBE5
YSLPAPELPEAFFGT	AHCTF1	1091	Q8WYP5
DPGAPPYDSLQTYAF	CDH7	721	Q9ULB5
FLSQPSGDFSSPFYP	DMBT1	2011	Q9UGM3
AAYPSVSYPSLPAGD	SEC24B	191	O95487
ALPSASSAYFPGQLP	SASS6	641	Q6UVJ0
AADSDPSVPPYDTAL	CDH15	721	P55291
PPATAYDAPASAFGS	PPP1R13L	206	Q8WUF5
ITVAYPPDTDTPGFA	KDSR	211	Q06136
IFYSITGPGADSPPE	CDH3	141	P22223
YFLSPGAAGPDPRTA	FAM8A1	176	Q9UBU6
PSPDGFSPYSPEETN	MAP3K1	291	Q13233
FNLSPADPDGKSDPY	FER1L6	1366	Q2WGJ9
GPPSPLSEASSGYFS	KIF13B	1556	Q9NQT8
LAEPGSFLDYPSTEP	RTN1	516	Q16799
PRVLADSFPGSSPYE	SIDT2	341	Q8NBJ9
SGISTPSDNYDFPPL	SPATA22	41	Q8NHS9
GFTELPDAPYDSDSG	BMT2	371	Q1RMZ1
DGAASPDSYTEEPAP	TAL1	296	P17542
LYVLEAATAGSPPPS	NBEAL2	1291	Q6ZNJ1
PYTAIASPDASGIPV	PIP4P2	41	Q8N4L2
YPGPFPEAISSSADP	SLCO5A1	821	Q9H2Y9
FPETPYTVSPAGADR	SIPA1L3	1136	O60292
APSSYDPLALSELPG	SIK2	891	Q9H0K1
GAPLPPARSDSYAAF	SHROOM3	381	Q8TF72
QATPAPGFKSAFSPY	SETD1B	386	Q9UPS6
GFYPAATFSSSPAPG	MYCBP2	21	O75592
SPSPEASALLYQPYG	WIZ	396	O95785
HAPYISIAGDDPPAS	TMEM150C	51	B9EJG8
SPGLFPSTSEYPGDS	STARD9	3866	Q9P2P6
VFPDSPGAYEAESPS	POLD3	336	Q15054
SAPFLAPPGAGSYAA	PRR12	596	Q9ULL5
YSPPDTSPANRSFVG	NFIC	476	P08651
AASAYSSAPGEAPPS	HOXA13	101	P31271
DSASPESDAPGPVYA	URB1	2081	O60287
YSAAELSPPGPALAE	STARD8	791	Q92502
YSFSGPPEPVLLDSS	SEC23A	626	Q15436
TGPSFTFPSDVPYQA	SH3RF1	376	Q7Z6J0
VPDYTASPPAGDSAR	LINC00612	61	Q8N6U2
DPYGPAGSDPSLEFL	COASY	271	Q13057
TPFSSAAALPPGSYA	CLASP1	621	Q7Z460
GDEPPVFSRPISASY	TSG101	136	Q99816
YPAASPTPHAAFLAD	YIF1B	61	Q5BJH7
FFVNPAGEVSAPSYP	SPART	231	Q8N0X7
SPAAEDASPSGYPYS	USP6NL	791	Q92738
KSPAAPYFLGSSFSP	WEE1	126	P30291
DPPPLFDDTSGGYSS	YIF1A	21	O95070
AAAASYLAEPPGSPT	nan	51	Q6ZUT4
ASPFATPDQGKADPY	ZDHHC3	281	Q9NYG2
HSELPFAAADPYSPA	VGLL2	166	Q8N8G2
PAPFYVADGSLHPSA	TCF3	211	P15923
TLQSPGYDPSRPESF	PKMYT1	91	Q99640
EFSTYPPAATEGPNI	RNF34	46	Q969K3
AAATAGAPTALPAYP	TMEM158	166	Q8WZ71
LAAPFPAPAVYSDAT	PLCH2	1111	O75038
PAPAVYSDATGSDPL	PLCH2	1116	O75038
SPPATPEQGLSAFYL	SPDEF	46	O95238
GLPDTPAAPETSTNY	TICAM1	286	Q8IUC6
VDDQSPPAYPGSGDT	SUSD4	406	Q5VX71
PVLDFAPPGASAYGS	WT1	36	P19544
PYFGKEEPSVAPSST	NDUFAF2	136	Q8N183
PEAPDSGRSAPYSAA	TBX6	371	O95947
GRSSAPYFSAECPDP	TBCK	726	Q8TEA7
PVFLSYSEPEGSAGP	SNX19	311	Q92543
ESRESYDAPPTPSGA	WRNIP1	106	Q96S55
TPFSGPPTSQADLDY	PIGO	781	Q8TEQ8
SPPFFGEPDYPSAED	TMC5	216	Q6UXY8
AVSATAYPDTPAEFP	TMEM42	11	Q69YG0
PYSSPDNGEAILDPS	ZNF746	401	Q6NUN9
FYGPDPPTITVSSDR	VSIG10L	396	Q86VR7
DPPFSAYPAVLGAAG	VSIG10L2	696	P0DP72
LPGYAPSDPDLNASY	TMEM271	351	A0A286YF58
SSIYPADGPPAFSLG	UBQLN3	121	Q9H347
ADASPPYARVPSGET	ZNF219	681	Q9P2Y4
SDASLPGDPEAYPAA	WNK3	1221	Q9BYP7
YTPFANGPSDTPEEI	RPS6KA1	611	Q15418
PSDAPSSGTVDPQLY	NAALADL2	151	Q58DX5
DELLDSPPASPSGSY	NACAD	206	O15069
YGLSDPSEPSEPIAL	MYOM3	581	Q5VTT5
SFGSHLPDCSTPPYE	NEUROD4	236	Q9HD90